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ABSTRACT 
The sensory organelle primary cilium is involved in sensing and transducing relevant signaling 
cascades in almost all cells of our body. These ciliary-mediated pathways impact cellular 
homeostasis and metabolism profoundly. However, it is almost entirely unknown whether the 
cellular metabolic state affects the assembly of cilia. This study investigates how O-linked β-N-
acetylglucosamine (O-GlcNAc), a sensor of cellular nutrients, regulates ciliary length. 
Pharmacological or genetic inhibition of O-GlcNAcylation led to longer length cilia and vice 
versa. Further biochemical assays revealed that both α-tubulin and HDAC6 (histone deacetylase 
6) were O-GlcNAcylated in vivo. In vitro enzymatic assays showed that O-GlcNAcylation of
either tubulin or HDAC6 promoted microtubule disassembly, which potentially caused ciliary 
shortening. Taken together, these results uncovered a negative regulatory role of O-GlcNAc in 
modulating the ciliary microtubule assembly. The crosstalk between O-GlcNAc and cilium is 
likely critical for fine-tuning a cellular response to nutrients, such as glucose, amino acids. 
Flagella of green algae, Chlamydomonas reinhardtii, have similar structure and function as 
mammalian primary cilia. Structurally, a flagellum consists of a microtubule-based axoneme 
surrounded by a specialized membrane extended from the cell membrane. An axoneme is 
composed of 9 doublet microtubules (DMTs) surrounded by two central singlet microtubules. 
The beating of the Chlamydomonas flagella relies on the force-generating motility appendages, 
including outer and inner dynein arms, radial spokes, and dynein regulatory complex (DRC) 
assembled onto DMTs in a highly specific and periodic manner. The highly organized and 
regularly arranged structures of DMTs make them an excellent natural template for synthesizing 
biomolecules by fusing target proteins with axoneme proteins. The concept was proven with 
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successful transport and localization of tagged inner junction protein FAP20 and radial spoke 
protein RSP3 into the inner junction and radial spokes of flagella. This project tested whether 
Chlamydomonas could be utilized as a template for synthetic biology by inserting fusion proteins 
FAP20-TEV-Beta-lactamase (Bla), estrogen receptor alpha (ER) and RSP3-TEV-Bla, ER. 
These results confirmed that flagella are capable of assembling protein arrays. The RSP3-TEV-
Bla and FAP20-TEV-Bla attached on the isolated flagella axoneme are enzymatically active; the 
flagella-bounded beta-lactamase was able to recycle for reuse; repeated deflagellation and 
regeneration can be used to increase the yield of tagged protein; RSP3-ER and FAP20-ER are 
able to bind and remove estrogen compounds. Altogether, the data indicate that flagella axoneme 
can serve as a template to synthesize biomolecules.  
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Basics of primary ciliary 
Primary cilia are microtubule-based hair-like structures that extended from the surface of cells. 
They were considered as vestigial organelles until recent publications revealed that they exist on 
most types of quiescent mammalian cells, such as smooth muscle, neurons, and pancreatic 
endocrine cells [1-4]. Primary cilia on different tissue types are distributed through various 
receptors, ion channels, and transporters on the ciliary membrane to transduce extracellular 
signals within the cell to regulate various vital processes, including development, organ function, 
and tissue homeostasis [2, 5, 6] (Figure 1-1). Localization and proper function of primary-cilium 
signaling receptors rely on proper ciliary formation. Hormone receptors somatostatin sst3 
receptor (Sst3R), melanin-concentrating hormone receptor 1 (Mchr1), insulin receptor (IR), and 
leptin receptor (LepR) all localize to hypothalamic neuronal primary cilia. Mis-localization of 
these receptors on neurons results in hyperphagia-induced obesity and type II diabetes [7-10]. 
Abnormal formation or dysfunction of primary cilia causes a series of human diseases, such as 
retinal degeneration, polycystic kidney disease, Bardet-Biedl syndrome, and Joubert syndrome, 
which are collectively known as ciliopathies [11]. Therefore, it is crucial to understand how 
ciliary formation and ciliary length are regulated. The regulation of ciliary formation and ciliary 
length will be discussed in the following two sections. 
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Figure 1- 1 Schematic presentation of primary cilium as a signaling hub. 
The ciliary axoneme and membrane proteins were transported to the ciliary compartment by IFT 
trains. Primary cilia on different tissue types are distributed through various receptors, ion 
channels, and signal transporters on the ciliary membrane to transduce extracellular signals 
within the cell and to play roles in various vital processes, including development, cell cycle 
progression, and tissue homeostasis. Ss3R, somatostatin sst 3 receptor; Mchr1, melanin-
concentrating hormone receptor 1; IR, insulin receptor; LepR, leptin receptor; IFT, intraflagellar 
transport. 
Regulation of ciliogenesis 
The first aspect is the regulation of cilia formation. Ciliogenesis is a process of cilia formation 
that occurs in an ordered set of steps. It starts with the transition of a mother centriole into a basal 
body, then the basal body migrating and docking at the apical plasma membrane, followed by a 







synthesis is restricted to the cytoplasm, elongation of the cilium is conducted by intraflagellar 
transport (IFT), which carries axoneme proteins and transports cargo from the basal body to the 
distal tip for construction [16-18]. Meanwhile, IFT is a bidirectional motor-driven complex that 
can also transport turnover proteins from the distal tip to basal body [17, 19, 20]. The axoneme is 
highly dynamic, undergoing assembly and disassembly constantly. When the cilium is elongated, 
the assembly rate is faster than the disassembly rate. When the cilium reaches steady state, the 
balance of the axoneme assembly and disassembly results in the final ciliary length [21, 22]. In 
summary, assembly and disassembly rate regulated by IFT is critical for determining ciliary 
length. 
 
Although the mechanisms of how cells are triggered to initiate ciliary assembly or disassembly 
are still mostly enigmatic, recent findings provide insights into the regulation of ciliogenesis [21, 
23]. First, ciliogenesis is highly dependent on cell cycle progression. The primary cilium is 
typically assembled during G1 or G0 phase and disassembled when the cell enters into mitosis 
[24, 25]. One possible explanation is that centrosome dynamics are precisely synchronized with 
the progression of the cell cycle [26, 27]. During the G1/S transition, centrioles need to 
translocate from the ciliary basal body to the cell interior to be duplicated, which will result in 
the resorbing of primary cilia [28]. Many centrosomal proteins such as CP110 and Cep97 that 
regulate cell cycle progression are also involved in ciliogenesis. Knocking out either CP110 or 
Cep97 prevents cytokinesis and formation of cilia [29]. Also, the mitosis regulator Aurora A and 
its upstream interaction protein HEF1 are localized to the basal body and are activated to 
promote ciliary disassembly. Further studies showed that HDAC6 acts downstream of Aurora A 







Besides, the transporter of ciliary proteins IFT is another factor controlling ciliogenesis. The IFT 
train size and speed are larger and faster, which can carry more axonemal precursors, in the 
growing cilia [21, 32]. Inhibition of Chlamydomonas IFT27, which is a Rab-like small G protein 
of IFT complex, results in disassembly of flagella as well as defects in cytokinesis [33].  
 
Ultimately, many growth factors and genes involved in ciliopathies participate in the regulation 
of ciliogenesis. Many cultured mammalian cell types grow cilia upon serum starving promotes 
quiescence [25, 26]. One explanation attributed to this phenomenon is that serum starvation 
synchronizes cells in G0 phase to induce ciliogenesis. Serum starvation-induced autophagy 
activation may also produce cilia by removing ciliogenesis inhibition factors such as oral-facial-
digital syndrome 1 (OFD1) from centriolar satellites. One finding showed that activation of 
autophagy rapidly degrades OFD1 at the centriolar satellites to induce ciliogenesis upon serum 
starvation. However, in the autophagy-deficient mutant cells, OFD1 accumulates at the centriolar 
satellites and impairs ciliogenesis [34]. Moreover, disruption of the intact phosphoinositide 
signaling pathway is another factor that promotes ciliogenesis. The classic tumor suppressor 
gene VHL gene is involved in phosphatidylinositol 3’-kinase (PI3K)/Akt signaling pathway. 
Typically, VHL is a hypoxia sensor, but VHL can function in promoting ciliogenesis. Deficiency 
of VHL in primary mouse embryonic fibroblasts causes loss of cilium [35-37]. PI3K is 
counteracted with VHL activity to restrict ciliogenesis. PI3K can also inactivate GSK3 through 
Akt-mediated phosphorylation to inhibit ciliogenesis [38]. These results indicate that GSK3 and 
VHL may have overlapping functions in promoting ciliogenesis. Overall, regulation of 
ciliogenesis is mainly regulated in three aspects, including cell cycle progression, IFT, and 
signaling pathways. 
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Ciliary length regulation 
The second aspect is the regulation of ciliary length regulation. Primary cilia are sensory 
organelles that can be found on almost all vertebrate cells and possess sensory function [1]. 
Ciliary length varies extensively among different cells types. The length could range from 1 m 
on vascular endothelial cells to approximately 200 m on mammalian olfactory neurons, but 
ciliary length is constant for a given cell type [39, 40]. These observations suggest that ciliary 
length is subject to cell-type-specific regulation, and an optimal range is essential to ensure 
proper functionality of the cell. Indeed, the ciliary length is tightly regulated, either shorter or 
longer length of cilia leads to defects in function [41, 42]. In humans, the abnormal ciliary length 
correlates with various diseases, such as polycystic kidney disease [43, 44]. The mechanisms of 
ciliary length regulation have been studied extensively and can be briefly summarized into the 
following categories.  
1. The assembly and disassembly balance regulate ciliary length
First, the ciliary length is regulated by a balance between axonemal assembly and disassembly, 
which is dependent on IFT machinery [22]. The IFT anterograde transports proteins from the 
base to the distal tips, which is catalyzed by kinesin motors; the IFT retrograde transports 
turnover proteins from the distal tip to the cell body, which is catalyzed by dynein motors [20]. 
IFT complex is composed of three sub-complexes: motor proteins, complex A, and complex B. 
Kinesin is a heterotrimeric complex consisting of two motor proteins KIF3A and KIF3B, and a 
nonmotor subunit KAP3. Dynein is the same as cytoplasmic dynein 2 [45-48]. IFT-A contains 6 
known proteins and IFT-B contains at least 15 known proteins, which are not listed here [40]. 







result in accumulation of IFT proteins in the stumpy cilia, while IFT-B mutations lead to short or 
deficient of ciliary assembly. The results suggest that IFT-B is more important for anterograde 
transportation, and IFT-A is more critical for retrograde transportation [21]. Recent findings 
indicate that BBSome may be another subset of IFT complex, which participates in transporting 
membrane proteins to the cilium [49, 50]. BBSome is composed of 7 BBS proteins (BBS1, 
BBS2, BBS4-9) [51]. Some BBS mutations may still assemble cilia but with minor functional 
defects, however, bbs-1, 7, 8 loss-of-function mutations result in dissociation of IFT-A and IFT-
B and complete ciliary defects [52-54]. 
 
It has been observed that axoneme assembly and disassembly happen continuously at the distal 
tip of flagella even after reaching their final length, which indicates that the axoneme is a highly 
dynamic structure [22]. When flagella reach a steady state, the assembly rate equals the 
disassembly rate at the distal tip and results in the final length of flagella [22, 55]. Disrupting the 
balance between axoneme assembly and disassembly by inhibiting IFT pathways induces cilia 
shortening gradually [22, 56]. The results indicate that the axoneme turnover is critical for the 
ciliary length regulation. Due to the disassembly rate is constant, the modulation of assembly rate 
is the key to regulate ciliary length. Findings showed that IFT is one factor participating in the 
regulation of the assembling rate. Reduction of IFT rate leads to shortening of ciliary length [22]. 
Moreover, Chlamydomonas fla10 is a temperature permissive mutant, which mutated on the 
subunit of anterograde motor kinesis-2. Flagella of fla10 cells gradually resorb when transferred 
to the restrictive temperature due to the deficiency of anterograde transport [57, 58]. The 








2. PTMs of axoneme regulate ciliary length 
In addition, stability and assembly of axoneme are regulated by various types of post-
translational modifications (PTMs) on the axonemal - and - tubulins, such as acetylation, 
detyrosination/tyrosination, polyglutamylation, and polyglycylation [59-62]. It is believed 
soluble - and -tubulin dimers are largely unmodified while highly post-translational modified 
when incorporated into MTs. Thus, various tubulin PTMs are accumulated in stable, long-lived 
microtubules, which has been observed in several studies [63-65]. The following three 
paragraphs discuss the modifications of acetylation, detyrosination, and polyglutamylation in 
regulation ciliary length. 
 
Firstly, Tubulin acetylation is considered a hallmark of stabilized MTs and microtubular 
structures such as axoneme [66, 67]. Typically, acetylation occurs on lysine 40 (K40) of -
tubulin and towards the lumen of microtubule as soon as MT assembled [60, 68, 69]. Findings 
showed that tubulin acetylation is associated with long-lived MTs and promotes motor protein 
kinesin-I binding and trafficking on MTs [70, 71]. Acetylation of tubulin is mainly catalyzed by 
enzymes alpha-tubulin acetyltransferase 1 (TAT1) and MEC17. Both TAT1 and MEC17 
acetylate K40 of -tubulin. Disrupting either of the genes TAT1 or MEC17 abolishes tubulin 
acetylation and labile MTs [72-75]. Ciliary axoneme acetylation is only catalyzed by TAT1 
[74]. By contrast, two enzymes catalyze tubulin deacetylation, histone deacetylase 6 (HDAC6) 
and SIRT2 (the human Sir2 orthologue). Both of them are members of the histone deacetylase 
family. Knockdown or pharmacological inhibition of HDAC6 increases tubulin acetylation and 








Furthermore, the PTM detyrosination is the first modification identified to regulate MTs 
dynamics [80]. Due to the C-terminal tail domains (CTTs) of - and -tubulins are both flexible 
domains locate on the surface of MTs, many microtubule PTMs happen on the CTTs, such as 
detyrosination [69, 81]. Most isotypes of -tubulin contain a tyrosine at the C-terminal of MTs. 
This tyrosine is usually removed by tubulin tyrosine carboxypeptidase (TTCP), which exposes a 
C-terminal glutamic acid and stabilizes MTs through suppressing the plus end dynamics [82, 83]. 
The modification of tyrosine is catalyzed by tubulin tyrosine ligase (TTL) [84]. Despite the fact 
that TTCP prefers acting on microtubule polymers, TTL prefers tubulin dimers as a substrate to 
interfere with polymerization. Findings showed that overexpression TTL inhibits MT 
polymerization [85, 86]. This result is consistent with the observation that the detyrosination 
level in the newly assembled axoneme is much higher than the old axoneme [62, 67]. Overall, 
the findings indicate that detyrosination stabilizes axoneme while tyrosination promotes 
axoneme disassembly. 
 
Lastly, polyglutamylation of - and -tubulins prominent in stable MTs such as axons of 
neuronal cells, mitotic spindles, and axoneme of primary cilium [87-89]. TTLL1 (TTL-like 1) 
and many other subtypes are the enzymes that catalyze the tubulin glutamylation [90]. For 
example, the observation that blocking glutamylation inhibits the motility of sea urchin sperm 
axonemes suggests that tubulin glutamylation is involved in regulating the ciliary dynein activity 









In summary, precursor tubulin undergoes diverse PTMs during cilium assembly, which 
highlights the importance of tubulin PTMs in the axoneme assembly and stability. For instance, 
acetylation and detyrosination regulate axoneme stability by interacting with motors and plus-
end capping proteins, loss-of-function of modifying enzymes studies showed glutamylation is the 
most critical one function in axoneme assembly and stability [92]. However, many other PTMs, 
such as phosphorylation, sumoylation, and ubiquitylation, are also worth investigation. 
 
3. Signaling pathways regulate ciliary length 
Finally, studies in many different systems have revealed broad-spectrum signaling molecules 
involved in ciliary length regulation [93, 94]. The observation that lithium treatment elongates 
cilium length suggests that cAMP plays a role in ciliary length regulation. Moreover, 
heterotrimeric G proteins, second messengers cAMP, cGMP, Ca2+, and downstream effectors, 
such as protein kinase A and MAP kinase signaling, all affect ciliary length [95-99]. The best-
studied signaling pathway in regulating ciliary disassembly is the one mediated through mitotic 
kinase Aurora A, which phosphorylates and activates downstream HDAC6 at the basal body to 
deacetylate tubulin, which in turn promotes ciliary disassembly. Serum stimulation induced 
expression and activation of HEF1 at basal body contributes to the stabilization and activation of 
Aurora A to modulate ciliary disassembly [30, 31]. Another set of mitotic kinases responsible for 
ciliary length regulation is the NIMA-related kinases (NEKs). There are 11 ortholog Nek genes 
in the human genome. Most of them have cell cycle-related functions while some such as Nek1 
and Nek8 localize to centrosomes/cilium and function in regulating ciliary length [100-102]. 
Mutations in Nek1 and Nek8 lead to ciliary signaling defections and contribute to ciliary 







produces extra-long renal cilia, while the loss of Nek1 induces significantly shorter length [44, 
105, 106], indicating that abnormal ciliary length contributes to the pathology of kidney 
dysfunction. 
 
Additionally, ciliary signaling pathways involved in the development, such as sonic hedgehog 
(Shh), Wingless (Wnt), and Notch, affect ciliary assembly or length control [107-109]. Inhibition 
of Gsk3, which is a kinase function in the Wnt pathway to phosphorylate and degrade -
catenin, induces significantly elongated cilia both in Chlamydomonas and mammalian cells [110-
112]. To date, there is still a growing list of signaling molecules that participate in ciliogenesis 
and ciliary length control. 
 
Primary cilia as a signaling hub and their role in human diseases  
Primary cilium as a cellular organelle plays important role in physiology. Primary cilia have a 
significant function in cell signaling because the ciliary membrane contains a variety of 
receptors, ion channels, and signaling transporters. Even some of their downstream effector 
molecules are localized to the cilium or basal body as well. Primary cilia are coordinating diverse 
key processes from development to tissue homeostasis, such as differentiation, cell cycle 
progression, apoptosis, and autophagy. Depending on the cell types, signaling pathways vary, 
including receptor tyrosine kinases (RTKs), Hedgehog (Hh), Wnt, Notch, neuronal receptors, 
planar cell polarity (PCP), and a platelet-derived growth factor receptor (PDGFR) [2, 113-118]. 
A single primary cilium can incorporate multiple signaling pathways and respond to different 
stimuli, such as morphogens, hormones, and growth factors [2]. When the growth and 







signaling pathways will be activated. For instance, growth factor stimulated RTK results in 
activation downstream signaling pathways, such as MAPK cascade, PI3K-Akt kinase (AKT) 
kinase cascade, and Janus kinase (JAK)-signal transducer and activator of transcription (STAT) 
cascade [119]. In dermal fibroblast, PDGFR in primary cilia modulates the activation of PI3K-
AKT-Na+/H+ exchanger (NHE1) pathway to regulate cell migration [120, 121]. Also, the ciliary 
transforming growth factor  (TGF) is involved in left-right asymmetry regulation. Binding of 
Nodal- growth differentiation factor -1 (Gdf1) to TGF receptors result in the expression of 
target genes Lefty 2 and Pitx 2 to develop left-side morphogenesis [122, 123]. Many other 
factors, such as insulin growth factor (IGF), BBSome, leptin signaling, and hedgehog signaling, 
also transduce signaling to intracellular through primary cilia [124-126]. 
 
As discussed above, primary cilia transduce diverse extracellular signals into the cell. Therefore, 
it is not surprising that dysfunction of primary cilia causes a variety of human diseases, including 
left-right asymmetry defects, neurodevelopmental disorder, polycystic kidney disease (PKD), 
polydactyly, obesity, infertility, and cancers; as well as syndromes, such as Bardet-biedl 
syndrome (BBS), Alström syndrome (ALMS), Nephronophthisis (NPHP), Meckel syndrome 
(MKS), and Joubert syndrome (JBTS), are termed as ciliopathies [93, 127]. Many ciliopathies 
are caused by abnormal ciliary length or impaired ciliogenesis. Even a mild deviation from the 
normal range of ciliary length on a particular cell type is sufficient to generate pathogenic 
phenotypes. Therefore, understanding the mechanisms of ciliary regulation is critical for 









O-GlcNAcylation as one potential factor contributing to ciliary length regulation 
A tremendous amount of research has shed light on the primary cilium and its crucial roles in 
maintaining tissue homeostasis and the pathogenesis of obesity and diabetes in the past decades. 
However, the genetic and molecular mechanisms of how primary cilium dysfunction is involved 
in the etiology of obesity and diabetes still lack investigations. O-GlcNAc, a modification using 
UDP-GlcNAc as a substrate derived from the hexosamine biosynthetic pathway (HBP), regulates 
energy homeostasis through participating in insulin and leptin signaling pathways [128, 129]. 
Several findings recently enlighten a potential interplay between O-GlcNAcylation and primary 
ciliary length. The work of Yu et al. showed that primary cilia were fewer and shorter in the 
diabetic mouse eyes, trachea, and skin cells compared to wild type. Increasing O-GlcNAcylation 
levels of RPE1 cells in culture medium impaired ciliogenesis [130]. The results indicate that 
higher O-GlcNAcylation levels decrease ciliary length and ciliogenesis, which is partially 
supported by the previous finding that glucose deprivation promoted primary cilium formation 
[131]. However, the mechanisms of how cellular O-GlcNAcylation levels regulate the ciliary 
length are lacking. Another study showed that obese individuals have shortened and 
compromised functional primary cilia of adipose-derived mesenchymal stem cells (ASCs) in 
humans [132]. Elevated activities of Aurora A and HDAC6 contribute to the shortening of ciliary 
length. Also, the deficiency of ciliary signaling Hh may impair ASCs differentiation to adipocyte 
in obese individuals [132]. Because the elevated O-GlcNAcylation is directly linked to many 
metabolic diseases including obesity and diabetes, the results imply that the escalated O-GlcNAc 









The principles of O-GlcNAc modification 
O-linked -N-acetylglucosamine (O-GlcNAc) modification was unexpectedly discovered by 
Gerald W. Hart when purifying galactosyltransferase in 1983 [135]. O-GlcNAc modification 
generally happens on 10-20% of all nuclear, mitochondria, and cytoplasmic proteins of the cell 
[136]. O-GlcNAc is involved in diverse cellular processes, such as transcription, translation, cell 
signaling, cytoskeletal network dynamics, stress responses, and proteasomal degradation [137]. 
O-GlcNAc has been found not only in all cellular compartments, but also ubiquitous in all 
investigated eukaryotes, ranging from fungi, plants, worms, and insects to humans [135].  
 
The single pair of enzymes, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), respond to 
the dynamic cycling of O-GlcNAc from serine/threonine residues of the target protein (Figure 1-
2). OGT uses UDP-GlcNAc derived from the HBP as substrate donor to glycosylate target 
protein. O-GlcNAc is removed from target proteins by the enzyme OGA. The gene encoding 
OGT is evolutionarily conserved from plants to humans. The human OGT gene maps to 
chromosome Xq13.1, a region associated with Parkinson’s disease [138]. Alternative splicing of 
the OGT gene results in three isoforms: the nucleocytoplasmic/full-length OGT (ncOGT, 
~110kD), mitochondrial OGT (mOGT, ~90kD), and short form of OGT (sOGT, ~78kD), which 
target to the nucleus, mitochondrion, and cytosol respectively. All OGT isoforms contain an N-
terminal domain with different numbers of tetratricopeptide repeats (TPRs), which mediate 
protein-protein interactions of the enzyme with the targeting proteins, and a C-terminal domain 
that is homologous to glycogen phosphorylase. The C-terminal domain contains the substrate of 







postsynaptic density revealed that about half of the O-GlcNAc modification sites have a 
PVS/TS/T or TTA motif, there is no preferred peptide sequence for binding to OGT [138].  
 
The enzyme OGA is highly conserved in eukaryotic species, especially in mammals, but absent 
in prokaryotes and yeasts. OGA is encoded by the gene of meningioma expressed antigen 5 
(MGEA5) in mammals. There are two spliced isoforms of OGA (short and full-length). The full-
length ncOGA localizes predominantly in the cytosol while the short form sOGA resides in the 
nucleus. Both isoforms contain the C-terminal glycosidase domain and the same first 662 amino 
acids. While the sOGA has an alternative carboxy-terminal sequence with 15 amino acids while 
ncOGA has a domain that homologous to the histone acetyltransferase (HAT) family at the C-
terminal. However, the regulation of OGA activity is mostly a mystery. It is known that OGA 
can be O-GlcNAcylated and cleaved by activated caspase-1 at the site of Asp413, but such 
cleavage does not affect OGA activity [138].  
 
Both OGT and OGA are ubiquitously expressed but with high expression in immune cells, brain, 
and pancreas. Maintaining homeostasis of O-GlcNAcylation is vital for its normal function in 
many cellular processes, such as transcription, translation, and signal transduction [135]. 
Dysregulation of O-GlcNAcylation homeostasis is contributing to the pathogenesis of a plethora 










Figure 1- 2 Cycling of O-GlcNAc modification. 
2-5% of glucose in taken by mammalian cells enters into the HBP directly. UDP-GlcNAc will be 
produced after many steps’ reaction. The enzyme OGT uses UDP-GlcNAc as a substrate to 
catalyze glycosylation of the target protein. GlcNAc will be added on the Ser/Thr of the target 
protein. The modification is removed by the enzyme OGA. HBP, hexosamine biosynthetic 
pathway; OGT, O-GlcNAc transferase; OGA, O-GlcNAcase.  
 
The regulation of dynamic cycling of O-GlcNAc 
O-GlcNAc modification is one of the primary mechanisms for cells to sense the abundance of 
nutrients. About 2-5% of cellular glucose is converted to UDP-GlcNAc through the HBP [144].  
The production of UPD-GlcNAc is the integration of HBP with the metabolism of carbohydrates, 
amino acids, fat, and nucleotides, which renders the concentration of UDP-GlcNAc highly 
dependent on nutrient flux and metabolite availability [129, 145, 146]. Meanwhile, the activity of 
OGT is highly responsive to UDP-GlcNAc concentrations. Therefore, the cellular O-
GlcNAcylation level depends on the metabolic state of the cell and is considered as a nutrient 
sensor [147]. For example, increasing the intracellular level of UDP-GlcNAc leads to elevated 







(25 mM) increases cellular O-GlcNAcylation levels compared to cells cultured in average 
glucose (5.5 mM) [150]. These examples support that O-GlcNAc is a cellular nutrient sensor. 
 
Furthermore, O-GlcNAc interplays extensively with phosphorylation to regulate protein’s 
activity. They share some common characteristics, such as both target Ser/Thr residues of the 
target proteins, are highly dynamic, and function in cellular processes like transcription, 
translation, cell division, and cell signaling [146]. When the global cellular O-GlcNAcylation 
level was raised through the treatment of OGA inhibitors, decreased phosphorylation on ~33% of 
phosphor-sites and increased phosphorylation on ~18% of phosphor-sites can occur [151]. The 
results indicate that elevated O-GlcNAcylation levels have different effects on phosphorylation 
modification at different sites. Indeed, there are generally three types of interplay between these 
two modifications. First, O-GlcNAcylation and phosphorylation may compete for the same 
modification sites on the target proteins. This competition alters the activity or stability of the 
proteins. For example, the anti-apoptotic protein Akt increases O-GlcNAc and decreases 
phosphorylation at Ser473 to promote apoptosis [152]. Second, the O-GlcNAc and 
phosphorylation modification occurs within a range of ~10 amino acids in many cases. The 
balance between O-GlcNAcylation and phosphorylation is likely to influence the target protein’s 
function. For instance, O-GlcNAc modification of many cytoskeleton proteins is decreased upon 
activation of protein kinase C (PKC) and protein kinase A (PKA), while O-GlcNAc modification 
is increased when PKC is inhibited [138]. Last, the phosphorylation and O-GlcNAcylation on the 
same protein can be additional or synergistic. For example, increased O-GlcNAcylation of the 







simultaneously modified with O-GlcNAc and phosphorylation [153]. Other examples are also 
seen on insulin receptor substrate (IRS) and AMP-activated protein kinase (AMPK) [134].  
 
At last, some kinases are involved in O-GlcNAc cycling regulation. Enzymes OGT and OGA are 
phosphorylated by various kinases to modulate their activity and interaction with their substrates, 
including calcium/calmodulin-dependent protein kinase IV (CaMKIV), glycogen synthase kinase 
3 beta (GSK3), and AMPK [146, 154, 155]. For instance, GSK3 phosphorylates and activates 
OGT on S3 or S4. However, this phosphorylation competes with O-GlcNAcylation to regulate 
OGT activity [155]. Also, inhibition of GSK3 will modulate O-GlcNAcylation profiles. On the 
one hand, many proteins have elevated O-GlcNAcylation levels, such as cytoskeletal and heat 
shock proteins. On the other hand, many other proteins have diminished O-GlcNAcylation 
levels, such as transcription factors and RNA-binding proteins [156]. In addition, AMPK is an 
energy sensor protein kinase in response to intracellular ATP levels. AMPK is positively 
regulated by O-GlcNAcylation, and in turn phosphorylate OGT on T444 regulates its substrate 
selectivity [154, 157]. GSK3 and AMPK are also kinases involved in ciliary length regulation, 
which further indicate the potential interplay between O-GlcNAcylation levels and primary 
ciliary length. 
 
O-GlcNAc in metabolism homeostasis and in human diseases 
O-GlcNAc as a nutrient sensor is highly sensitive to the availability of glucose, amino acids, 
fatty acids, and nucleotides, which will feed HBP flux to produce UDP-GlcNAc. However, OGT 
has different substrate specificity at different UDP-GlcNAc concentration. It has been clear that 







nearly all cellular processes and cellular physiology to maintain proper homeostasis [129, 144]. 
Dysregulation of nutrient homeostasis or nutrient excess leads to abnormal O-GlcNAcylation of 
proteins with corresponding effects on cellular processes and contributes to the etiology of 
humans diseases, such as diabetes, neurodegeneration, and cancers [144].  
 
First, O-GlcNAcylation participates in regulating glucose metabolism. Altering the extracellular 
glucose levels modulates cellular O-GlcNAcylation levels via changing the flux of the HBP 
[158]. Meanwhile, O-GlcNAc regulates all enzymes’ activities in the glycolytic pathways in 
turn. Elevated O-GlcNAcylation levels by OGT overexpression or OGA inhibition decrease 
glucose metabolism through promoting O-GlcNAcylation phosphofructokinase I (PFK1) on 
S529 to attenuate the activity of PFK1 [144]. Also, increased O-GlcNAc damps signaling 
pathways that promote glucose transport, such as mTOR, PI3K-Akt, and AMPK pathways [159-
161]. Furthermore, O-GlcNAc down-regulates the insulin-signaling pathway and contributes to 
insulin resistant under a prolonged hyperglycemia condition [162, 163]. Several key proteins in 
the insulin-signaling pathway are O-GlcNAcylated, and the O-GlcNAc modification of them 
impairs the metabolic pathways of insulin receptor (IR)/IR substrate (IRS)-1, 2/PI3K/Akt [164]. 
The insulin-signaling pathway is mediated by primary cilia. For example, O-GlcNAcylation of 
IRS-1and IRS-2 may interplay with phosphorylation to regulate the activity of their downstream 
signaling cascades [165, 166]. Also, increased O-GlcNAcylation level through OGA inhibitor O-
(2-acetamidO-2-deoxy-D-glucopyranosylidene) amino-N-phenylcarbamate (PUGNAc) treatment 
diminishes activation of Akt. Together with other studies, high O-GlcNAc attenuates insulin 
signaling and contributes to insulin resistance, which is a hallmark of type II diabetes [167-170]. 







prolonged hyperglycemia, and glucosamine treatment, raises O-GlcNAcylation levels and leads 
to insulin resistance and eventually type II diabetes [133, 171]. 
 
Furthermore, reduced O-GlcNAcylation contributes to the etiology of neurodegeneration, such as 
Alzheimer’s disease (AD) and Parkinson’s disease (PD). Due to the impaired glucose 
metabolism in AD brain tissue, decreased O-GlcNAcylation of numerous neural proteins 
contributes to the development of AD. The tau protein associated with microtubule is one of the 
most well-studied proteins [172-174]. Abnormal oligomerization of tau caused neurofibrillary 
tangles (NFTs) is one of the defining pathological features of AD [142]. The status of tau is 
regulated reciprocally by O-GlcNAcylation and phosphorylation. Decreased O-GlcNAc 
modification leads to hyperphosphorylation and aggregation of tau, which contributes to NFTs 
and pathologies of Alzheimer’s disease [174]. Other hallmarks of AD are the accumulation of 
amyloid beta (A) plaques in the extracellular space, synaptic loss, and dementia. The A plaque 
is derived from amyloid precursor protein (APP), [175]. It has been shown that APP is O-
GlcNAcylated. Increased O-GlcNAcylation impairs A peptides levels and plaque formation in 
the brain and rescues memory impairment [176, 177]. Furthermore, the aggregation of -
synuclein, the key pathogenesis of Parkinson’s disease, is partially due to the impaired O-
GlcNAc cycling and leads to the neuronal death [178, 179]. Therefore, the development of OGA 
inhibitors as a therapeutic target might offer the opportunity to alter disease progression and 
provide useful treatment of neurodegenerative diseases [142, 144]. 
 
Lastly, total O-GlcNAcylation levels are elevated in cancer cells with the increased expression of 







cells, which suggests the dysregulation of cellular metabolism and is considered a hallmark of 
cancer cells [181, 182]. The elevated glucose and glutamine flux will feed in the HBP and 
contribute to O-GlcNAc mediated activation of AMPK and mTOR signaling pathways [183]. In 
addition, the key cell growth and metabolic regulator hypoxia-inducible factor 1-alpha (HIF-1) 
were activated in cancer cells to facilitate aerobic glycolysis through up-regulating glucose 
transporter GLUT1 and hexokinase 2 (HK2). HIF-1 is not O-GlcNAcylated directly, however, 
HIF-1 is stabilized in elevated O-GlcNAcylation levels in breast cancer cells [180, 184, 185]. 
Several studies showed that primary cilia are decreased or lost in cancer cells [186]. The elevated 
O-GlcNAcylation levels may contribute to the activation of kinases, such as AMPK, mTOR, and 
HIF-1, to promote ciliary disassembly in tumor cells. Overall, understanding more fully the ties 
between nutrient sensor O-GlcNAcylation and metabolism will provide novel approaches to the 
treatment of obesity, diabetes, neurodegenerative diseases, and cancer [144]. 
 
Tools for studying O-GlcNAc 
With increased understanding of O-GlcNAc regulatory enzymes, several biological tools have 
been developed, including cell lines with genetic modifications to overexpress and knockdown 
the OGA/OGT enzyme. Importantly, pharmacological inhibitors such as OGA inhibitors 
PUGNAc, Thiamet G, GlcNAcstatin G, and OGT inhibitor Alloxan are now available [187] 
(Figure 1-3). PUGNAc is a non-selective inhibitor of the nuclear and cytoplasmic OGA, which 
induces insulin resistance and leads to Type II diabetes. In searching for highly selective OGA 
inhibitors, two specific and selective inhibitors, Thiamet G and GlcNAcstatin G, were later 
synthesized [188]. Alloxan is the first OGT inhibitor described, and OGT activity is inhibited in 
a dose-dependent manner with complete inhibition at a concentration of 1 mM [189]. All these 








Figure 1- 3 Tools for studying O-GlcNAc. 
Cellular O-GlcNAcylation levels can be manipulated either genetically or pharmacologically. 
Genetically overexpression and knockdown the enzyme OGT can elevate or attenuate O-
GlcNAcylation levels. Inhibitors such as OGA inhibitors PUGNAc, Thiamet G, GlcNAcstatin G 
can increase O-GlcNAcylation levels, while OGT inhibitor Alloxan decreases O-GlcNAcylation 
levels. TG, Thiamet G; SG, GlcNAcstatin G. 
 
Summary 
Primary cilia are a microtubule-based organelle present on most mammalian cells. Various 
receptors and ion channels are localized on the ciliary membrane. The primary cilia function as a 
signaling hub to transduce extracellular signals, such as morphogens, hormones, and growth 
factors, to the intracellular and active the primary ciliary mediated signaling pathways. The 
proper ciliogenesis and ciliary length regulation are essential for the receptors localized to the 
primary cilia and play functions in transducing signal. Because primary ciliary mediated 
signaling pathways are mostly related to development, energy metabolism, and tissue 
hemostasis, the dysfunction of primary cilia usually causes metabolic-related disorders, such as 
obesity, diabetes, and cancers. These observations indicate that nutrient sensors may be factors 







primary cilia and nutrient status raise the possibility that the nutrient sensor O-GlcNAc as a 
potential contributer to ciliary length regulation. O-GlcNAcylation levels are tightly regulated by 
the availability of nutrients status, including glucose, amino acids, fatty acids, and nucleotides. 
Fluctuating O-GlcNAcylation levels regulate multiple cellular processes, such as transcription, 
translation, protein activity and stability, and autophagy. The ciliogenesis and ciliary length 
regulation factors, such as PI3K, AMPK, mTOR, Akt, GSK3, and IRS1/2, are either O-
GlcNAcylated directly, or their activity is regulated by O-GlcNAcylation. These investigations 









Synthetic biology and its applications  
Synthetic biology is an interdisciplinary approach that takes advantage of biology, genetic 
engineering, and computer engineering to build artificial biological systems for pharmacology, 
medicine, agriculture, and environmental applications. In general, the purpose of synthetic 
biology is to design and construct novel artificial biological pathways, organisms or devices, or 
to redesign existing natural biological systems to deliver useful applications [190]. In the past 
decade, numerous synthetic gene circuits have been created and applied in biofuels, detectors for 
biomedical and chemical weapons, disease diagnosis, and genetic therapies [191].  
 
One application of synthetic biology is in designing biosensors. Biosensors often refer to an 
engineered organism that can be used to detect the presence of chemicals. Bacterial biosensors 
combine the promoter/operator of a stress response gene with reporter genes to detect toxic 
metals [192]. One example is a sulfur-oxidizing bacterial (SOB) biosensor used for detecting 
toxic metals in water. When there are toxic chemicals present, SOB will be inhibited and cause 
an increase in pH and a decrease in electrical conductivity (EC), and the changes can be detected 
by EC and pH meters [193]. Other applications of synthetic biology are to produce industrial 
enzymes with high activity and novel biomaterials. The production of biomaterials is based on 
using microbes as molecular foundries to produce genetically encoded materials [194]. For 
instance, recombinant E. coli expressing phytochelatin synthase (PCS) and metallothionein 
(microtubule) can be used to synthesize diverse metal nanoparticles. PCS synthesizes varying 
sizes of oligoglutathione peptides PCS that can form a metal complex with Cd, Cu, Ag, and Hg. 







common hosts of biomolecular structures, such as virus capsids and bacteria encapsulants used 
for the synthesis of biomaterials. However, these structures have limited capacity and lack the 
ability to incorporate the biomolecules into highly predictable and ordered constructs. The highly 
organized and regularly arranged structures of Chlamydomonas flagella makes it an excellent 
natural template for synthesizing biomolecules by fusing target proteins with axoneme proteins. 
 
Chlamydomonas as a model organism 
The unicellular green alga Chlamydomonas is an established model organism to study flagellar 
assembly, structure, and function [196]. There are many advantages of using Chlamydomonas to 
study flagellar dynamics and functions such as a simple life cycle, easy isolation of mutants, and 
applicable techniques for targeted gene silencing and gene editing. When considering using 
Chlamydomonas flagella as a template to synthesize biomolecules, the following advantages 
should be highlighted. First, Chlamydomonas is easy to culture synchronously in a large volume 
in the laboratory. Second, flagella can be easily detached and isolated for biochemical assays. 
Flagella can be detached and regenerated several times to increase the yield. After flagella 
detach, it only takes 1-2 hours to regenerate full-length flagella. Third, the flagellar proteome is 
completely sequenced. It is easy to do genetic modifications of any protein of interest. Fourth, 
there is an extensive collection of flagella protein null-mutations available, which can be used to 
express fusion genes without the background of endogenous proteins. Fifth, the target protein 
amount can be calculated precisely due to the known structural components of the axoneme. 
Lastly, no protease exists in the Chlamydomonas flagellar compartment. Therefore, the target 
protein should maintain its activity with no degradation after flagella are isolated. The 







Structure of Chlamydomonas flagellum 
Axoneme, as a backbone structure of Chlamydomonas flagellum, has been studied for over 30 
years. The axoneme is composed of nine doublets microtubule (DMTs) surrounding two central 
singlet microtubules. Besides microtubules, there are many other proteins or complexes 
necessary for its function. The 9 + 2 structure of the axoneme has a basic longitudinal repeat unit 
of 96 nm. Within each unit, there are periodically anchored four inner dynein arms (IDAs), 
several outer dynein arms (ODAs), one dynein regulatory complex (DRC), as well as two or 
three pairs of radial spokes (RS) [197] (Figure 1-4). This periodica nano-architecture of the 
axoneme makes it an excellent template for synthetic biology.  
 
Radial spoke is a T-shaped complex containing a stalk and a head that is composed of at least 23 
proteins. The stalk is anchored to the DMTs adjacent to the IDAs and projects toward the central 
pair of microtubules and the terminal globular head connect those two together [198]. In the 
paralyzed flagella mutant pf14, the defective gene product of radial spoke protein 3 (RSP3) 
results in the lack of all the other spoke components. In vitro experiments showed that amino 
acids 1-85 of RSP3 is necessary for axoneme binding, and fusion of amino acid 1-85 of RSP3 to 
an unrelated protein confers complete binding activity to the axoneme [199]. The results indicate 
that RSP3 is critical for the assembly of the entire spoke and may bind to axoneme directly. 
 
Each DMT consists of one complete A-tubule that composed of 13 tubulin protofilaments (PFs) 
and one incomplete C-shaped B-tubule composed of 10 PFs. The junctions between A- and B-
tubules are structures of the inner junction and outer junction. The outer junction is a closed 







bridge structure between A- and B-tubules formed by a smaller subunit of non-tubulin proteins 
[201]. Conventional electron microscope results showed that Chlamydomonas FAP20 mutant 
axonemes lack the IJ, and the further study revealed that labeled FAP20 localizes at the IJ. Lack 
of FAP20 will have motility defects with an abnormal symmetrical waveform. Immune-
fluorescent (IF) results showed that FAP20 localizes along the entire length of DMTs, and 
estimated that there is one FAP20 per 8 or 4 nm of DMT through comparing the fluorescence 
intensity of FAP20-GFP and RSP3-GFP [201]. 
 
Figure 1- 4 Schematic presentation cross-section structure of axoneme. 
The flagella axoneme is composed of nine doublet microtubules and a pair of central singlet 
microtubules. Several appendages structures involved in regulating axoneme motility are 
attached on the DMT, such as inner dynein arms, outer dynein arms, and radial spoke. DMT, 
doublet microtubules; RS, radial spoke; IDA, inner dynein arm; ODA, outer dynein arm. 
 
Chlamydomonas flagellar regeneration 
Flagella regeneration in Chlamydomonas was discovered fifty years ago [202]. When both 







Interestingly, if only one flagellum is removed, the other intact flagellum shortens at first while 
the amputated one regenerates, then both flagella approach to full length at the same rate after 
they attain an equal intermediate length [42]. The results indicate the flagellar regeneration is 
regulated by internally [202]. Generally, flagella start to extend rapidly after deflagellation by pH 
4.5 shock, then bringing the pH back to 7.0 and can reach their full length within two hours. The 
deflagellation and regeneration can repeat several times (Figure 1-5). 
 
Figure 1- 5 Flagella regeneration. 
Original flagella are detached by pH 4.5 shock then return the pH back to 7.0. Cell bodies keep 
culturing in aerobic environment to induce flagella regeneration. The process of flagella 
regeneration is monitored. The flagellar assembly is finished in about 90-120 min. Different 
strains or culture conditions may cause time deviation.  
 
Summary 
In the second part of the introduction, I discussed the application of engineering flagellar 
axoneme as a biosynthetic template. There are several advantages to do so. For example, 
Chlamydomonas cells are easy to culture in a large volume, flagella can be repeatedly detached 
and regenerated, fully sequenced flagellar proteome, nontoxic, and the well-studied axoneme 
structures enable precise calculation of amounts of final products. Then I introduced the 
axoneme appendages structures of RS and IJ. The RS and IJ components of RSP3 and FAP20 
have been used as adaptors to expression the fusion proteins in the mutant strains pf14 and im5. 
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O-GLCNACYLATION LEVELS REGULATE PRIMARY CILIARY LENGTH BY
PROMOTING MICROTUBULE DISASSEMBLY* 
Introduction 
Ciliary length in any specific type of cell falls within a narrow range. However, the lengths of 
different types of cilia vary much more widely. Therefore, the cell-specific length of cilia is 
obviously critical for cells to properly transmit sensory signals and generate directional motion if 
the cilia are motile. For instance, ciliary length in particular has been predicted to be a critical 
parameter in the model of the fluid dynamics of left-right patterning. Both longer and shorter 
ciliary length induce compromised left-right pattern establishment through affecting fluid flow 
[203] . Indeed, defective ciliogenesis and abnormal ciliary length have been widely implicated in 
ciliopathies. Many ciliopathies, such as (BBS), nephrononphthisis (NPHP), and Joubert 
Syndrome, are caused by abnormal ciliogenesis or failure to maintain assembled cilia [93]. A 
large number of disease genes are associated with syndromes including BBSome components, 
NPHP1-9, and Inositol polyphosphate-5-phosphatase E (INPP5E) [204]. Excessively long cilia 
are also associated with ciliopathies, for example, juvenile cystic kidney disease and tuberous 
sclerosis patients have much longer cilia than normal [93]. Additionally, defective ciliogenesis 
has been recently found to play important roles in cancer development. The ciliation frequency is 
greatly decreased in breast cancer tissues, and ciliary loss is prevalent in variety of kidney 
cancers [205]. 
*Reprinted with permission from “O-GlcNAcylation Regulates Primary Ciliary Length by Promoting Microtubule








Primary cilia are present on almost all differentiated human cells, such as kidney cells, 
fibroblasts, neurons and Schwann cells [206]. They play crucial roles, including sensing 
environment cues, transducing extracellular signals within the cells, processing developmental 
signals, and tissue hemostasis. Dysfunction of primary cilia contributes to a large spectrum of 
human genetic diseases and disorders, including PKD and BBS, retinal degeneration, brain 
malformations, obesity and diabetes. They collectively are termed ciliopathies [207].  
 
Protein O-linked β-N-acetylglucosamine (O-GlcNAc) modification (O-GlcNAcylation) on serine 
and threonine residues is one of the most abundant metazoan nuclear-cytoplasmic post-
translational modifications. The addition and removal of O-GlcNAc are catalyzed by two 
enzymes: O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), respectively [208]. UDP-
GlcNAc, as a nucleotide sugar donor of enzyme OGT, is derived from hexosamine biosynthetic 
pathway (HBP), which consumes 2-5% total glucose [162]. The HBP metabolic pathway 
integrates multiple metabolites, such as carbohydrates, amino acids, fat and nucleotides, to 
produce UDP-GlcNAc [125, 209, 210]. Therefore, O-GlcNAc is sensitive to nutrient flux, and 
the abundance of O-GlcNAc reflects the internal cellular nutrient level. O-GlcNAc modulates 
basic biological functions and plays broad roles in multifaceted biological processes, such as 
gene expression [211, 212], signal transduction [141, 213], protein degradation [214], cell cycle 
[215, 216], autophagy [217, 218],  and cellular stress [135]. Perturbation of O-GlcNAcylation 
alters biological homeostasis, which is involved in a plethora of human pathologies, such as 








O-GlcNAcylation regulates the activity of various components critical for metabolism and 
energy homeostasis, such as Protein kinase B (AKT), glycogen synthase kinase-3 (GSK3), 
hypoxia-inducible factor 1-alpha (HIF-1) and its transcriptional target glucose transporter 
(GLUT1). O-GlcNAcylation affects these proteins’ activity or their stability [180, 219]. 
Interestingly, the above proteins are all either localized to cilium or cilium related structures, or 
essential for ciliogenesis [141, 220-222]. The observations that these proteins either rely on the 
ciliary structure to function or are required for ciliary assemble, intrigue us to ask whether there 
is a crosstalk between O-GlcNAc and cilium.  
 
Primary cilia are microtubule-based organelles that extend from the surface of many types of 
cells and enriched with receptors, channels, and signaling molecules [2, 223, 224]. These 
ubiquitous structures, acting as “antenna” to transduce various extracellular signals, equip cells 
with diverse sensory functions. Many important signaling pathways, for instance, Hedgehog 
signaling pathway and Wnt signaling pathway, rely on primary cilia for proper function [210, 
225]. A wide range of ciliopathies arises due to defective cilia disrupting embryo development or 
tissue homeostasis [11, 226, 227]. 
 
The backbone of cilia, axoneme, with lengths normally ranging from 1 to 9 m in human [228]. 
Axonemal microtubules are highly stable and subjected to elaborate post-translational 
modifications (PTMs). Tubulin acetylation is the best-studied PTM on ciliary axoneme [71, 
229]. Acetylation of axonemal microtubules is catalyzed by -tubulin acetyltransferase 1 
(TAT1), a conserved enzyme exclusively expressed in ciliated organisms and required for 







(HDAC6), which is a tubulin deacetylase. Once activated, HDAC6 deacetylates acetylated 
axonemal microtubules. The deacetylated microtubules are unstable causing axonemal 
disassembly [31]. The deacetylase activity of HDAC6 is necessary and essential for ciliary 
microtubule disassembly [31, 232].  
 
The tubulin deacetylase activity of HDAC6 is regulated by phosphorylation. Aurora kinase A 
(Aur A) phosphorylates and actives HDAC6. The activated HDAC6 is then localized to the basal 
body and cilium by forming a complex with the scaffolding protein HEF1 [31]. The activation of 
Aur A-HDAC6-HEF1 cascade is consistent with the two waves of primary cilia disassembly 
occurred post serum addition to G0 cells at 2 h and 18 h, which correspond to G1 and mitosis 
phase, respectively. We reasoned that since O-GlcNAcylation and phosphorylation, these two 
prominent protein modifications, often tune protein’s activity by competing for the same Serine 
and Threonine residues, or modifying the residues in defined patterns [233], it is possible that the 
enzymatic activity of HDAC6 is regulated by O-GlcNAcylation as well. Indeed, in a prior LC-
MS proteomic analysis, HDAC6 is found to be an O-GlcNAcylated protein [234]. 
 
In this study, in cultured hTERT-RPE1 and IMCD3 cells, we demonstrate that the length of 
primary cilium negatively correlates with the cellular O-GlcNAc level. We also provide evidence 
that O-GlcNAcylation of either tubulin or HDAC6 promote axonemal microtubule disassembly. 
The cells appear to be able to attenuate the signaling response by limiting the size of cilium when 
nutrients are abundant. Clearly, the crosstalk between O-GlcNAc and cilium puts the cell in a 










Reduction of O-GlcNAc caused ciliary length elongation and increased the percentage of 
ciliated cells in cultured hTERT-RPE1 
OGT is the sole enzyme for addition of O-GlcNAc onto targeted proteins. To investigate the 
relationship between cilia and O-GlcNAc, we used small interference RNA (siRNA) to 
knockdown the expression of the enzyme OGT in hTERT-RPE1 cells (Figure 2-1 A). 
Immunoblotting (IB) of whole cell lysates verified that the level of O-GlcNAcylated proteins 
was significantly reduced when OGT expression was knocked down by siOGT, but remained 
expressed in cells transfected with a negative control siRNA to Firefly Luciferase GL2 (siGl2) 
(Figure 2-1 A1). Then we checked how reduction of protein O-GlcNAcylation affected ciliary 
length and percentage of ciliated cells. Immunofluorescence (IF) staining with antibodies against 
ciliary marker proteins acetylated-tubulin and IFT88 (Figure 2-1 A2) were used to highlight the 
ciliary structures. Since the staining with anti-IFT88 marked the ciliary base and tip well, we 
used it to measure the ciliary length. In cells transfected with the negative control siGl2, 24.18 ± 
6.8% of cells were ciliated. In contrast, in cells transfected with siOGT, the percentage of ciliated 
cells was increased to 55.38 ± 8.8% (Figure 2-1 A3). Additionally, the mean ciliary length of 
cells treated with siOGT was 5.07± 0.012 m, which was significantly longer than that of the 
cells treated with siGl2 (3.62 ± 0.322 m) (Fig. 2-1 A4). Therefore, a lower cellular level of O-
GlcNAcylation affected positively on ciliary assembly, promoting both cilia formation and 
elongation.   
 
To verify that the effects seen in siOGT treated cells were indeed caused by the reduction of 







siOGT cells (Figure 2-1 B1&2). Based on the band intensity on immunoblots of whole cell 
lysates, the expression of the endogenous OGT was decreased ~75% in cells treated with siOGT, 
but not in cells transfected with siGl2. The siOGT resistant HA-OGT-rescue, however, was 
successfully expressed when endogenous OGT was silenced, as shown by the IB with an 
antibody against HA (Figure 2-1 B1). We then checked whether the expression of HA-OGT in 
siOGT knockdown cells shortened the ciliary length or not (Figs. 2- 1 B2&3). Indeed, expression 
of HA-OGT in OGT depleted siOGT treated cells restored the ciliary length to normal. The mean 
ciliary length of cells expressed HA-OGT-rescue was at 3.9 ± 0.36 m, which was statistically 
shorter than the siOGT cells (4.99 ± 0.31 m). These results confirmed that protein O-









Figure 2- 1 Cilium length and percentage of ciliated cells were increased when O-GlcNAc 
level was reduced in hTERT-RPE1 cells. 
(A) The siOGT transfected cells were used to check the effects of O-GlcNAc reduction on ciliary 
length and percentage of ciliated cells. The siGl2 was the negative control. Three independent 
replicates were performed. The representative results are shown here. (A1) Immunoblots of cell 
lysates with indicated antibodies. (A2) Confocal images of cells co-immunostained with 
antibodies against acetylated-tubulin and IFT88. (A3) Bars represent the percentage of cells with 
primary cilia in siGl2 and siOGT cells (**p < 0.01 (p= 0.006)). (A4) The mean lengths of cilia in 
siGl2 and siOGT knockdown cells (*p < 0.05 (p = 0.0126)). (B) Expression of HA-OGT-rescue 
in siOGT knockdown cells restored ciliary length to normal. (B1) IB analysis of endogenous 
OGT and exogenous HA-OGT-rescue expressions. (B2) Confocal images of cells co-immuno-
stained with antibodies against IFT88 and HA. (B3) The mean length of cilia in groups as 
indicated on the graph (*p < 0.05 (psiOGT/HA-Vec = 0.044, psiOGT/HA-OGT = 0.33), ns, not significant). 
β-actin was used to show equal protein loadings on immunoblots. Scale bar equals 5 m. All 





































































































































































The O-GlcNAcylation mediated ciliary length regulation was not hTERT-RPE1 specific, but 
also seen in IMCD3 cells 
To evaluate whether the effect of O-GlcNAcylation on ciliary length was cell line specific, we 
examined whether changes of OGT expression regulated length of cilia in another cell line, 
IMCD3. Consistent with the results seen in hTERT-RPE1 cells (Figure 2- 1 A), the IMCD3 cells 
assembled longer length cilia when protein O-GlcNAcylation was inhibited by siOGT (Figure 2-
2 A). We did not detect a significant change of the percentage of ciliated cells when OGT 
expression was inhibited. The percentage of ciliated cells remained at about 40%. 
 
We reasoned that since O-GlcNAcylation inhibition induced ciliary elongation, it is possible that 
an elevated O-GlcNAcylation would lead to shorter length cilia. To test this idea, we transiently 
overexpressed an HA tagged OGT in IMCD3 cells. The increased protein O-GlcNAcylation in 
HA-OGT overexpressed cells was verified by IB (Figure 2-2 B1). The mean length of HA-OGT 
positive cells was 1.55  0.18 m, which was significantly shorter than that of control cells (2.61 
 0.4m) (Figure 2-2 B2&3). Taken together, in both hTERT-RPE1 and IMCD3 cells, there is a 
negative correlation between O-GlcNAcylation and ciliary length: the higher cellular O-








Figure 2- 2 Knockdown of OGT increased ciliary length, while HA-OGT overexpression 
decreased ciliary length in IMCD3. 
(A) The cells transfected with siOGT or the negative control siGl2 were used for analysis. Three 
independent replicates were performed. The representative results were shown here. (A1) IB 
analysis of O-GlcNAc levels in siGl2 and siOGT transfected cells with indicated antibodies. (A2) 
Confocal images of cells co-immunostained with antibodies against acetylated tubulin and 
IFT88. (A3) The siOGT knockdown cells had longer length cilia (*p < 0.05 (p = 0.0126)). (B) 
Overexpression of HA-OGT decreased ciliary length. (B1) IB analysis of O-GlcNAc levels in 
HA-Vector and HA-OGT overexpressed cells. (B2) Confocal images of cells co-immunostained 
with antibodies against acetylated tubulin and IFT88. (B3) The ciliary length was shorter when 













Inhibition of OGT or OGA by small chemical inhibitors confirmed the negative regulatory 
role of O-GlcNAcylation on ciliary length  
We selected three specific small chemical inhibitors: Thiamet G (TG) [236]  and GlcNAcstatin G 
(SG) for OGA [237, 238], and Alloxan (Alxn) for OGT [189], to treat both IMCD3 and hTERT-
RPE1 cells. The efficiency of these inhibitors on protein O-GlcNAcylation was first confirmed 
by IB against an anti-O-GlcNAc antibody (Figure 2-3 A1&B1). Consistent with prior published 
results, Alxn treatment decreased overall protein O-GlcNAcylation, while TG or SG treatment 
increased cellular O-GlcNAcylation. Then the length of cilia was measured using IF staining of 
ciliary marker protein IFT88. The length of cilia in either IMCD3 or hTERT-RPE1 was longer 
with Alxn treatment. The mean length of Alxn treated IMCD3 cells was 4.36  0.32 m, which 
was significantly longer than that of the control group (4.0  0.37 m). The mean length of Alxn 
treated hTERT-RPE1 cells was 3.79  0.09 m; while the length of control cells was 3.26  0.2 
m. Conversely, the ciliary lengths were significant shorter in cells treated with TG or SG. The 
mean length was shortened to 2.88  0.24 m with TG treatment, and to 2.72  0.32 m with SG 
treatment in IMCD3 cells. The TG and SG treatments caused the lengths of hTERT-RPE1 cells 
shorten to 2.73  0.11m, and 2.64  0.09m, respectively (Figure 2-3 A2&3, and B2&3). These 
small chemical treatment results were consistent with the observations obtained by perturbing the 








Figure 2- 3 The negative correlation between O-GlcNAcylation level and ciliary length 
verified by treating cells with OGT and OGA inhibitors. 
The IMCD3 (panel A) and hTERT-RPE1 (panel B) cells were subjected to OGT inhibitor 
Alloxan, or OGA inhibitor TG or SG, or control DMSO (A1&B1). IB analysis of O-GlcNAc 
levels in treated cells. β-actin was used to show equal protein loadings. (A2&B2) Confocal 
images of cells co-immunostained with antibodies against acetylated tubulin and IFT88. Scale 
bar equals 5 m. (A3&B3) The graph shows the statistical analysis of ciliary lengths of treated 
groups (*p < 0.05, **p < 0.01, A3: pAlloxan = 0.009, pTG = 0.0014, pSG = 0.004, B3: pSG = 0.018, 
pTG = 0.016, pAlloxan = 0.039). All data are mean  SD. 
 
O-GlcNAcylation of -tubulin promoted ciliary axoneme disassembly 
The ciliary length is determined by the rate of microtubule assembly and disassembly in the 
axoneme. In order to understand how O-GlcNAcylation affects ciliary length, we asked which 















































































































































study showed that O-GlcNAcylated -tubulin fails to incorporate into microtubules [239], 
suggesting an inhibitory role of tubulin O-GlcNAcylation in microtubule assembly. Using 
immuno-purified endogenous -tubulin, we confirmed that -tubulin was O-GlcNAcylated in 
hTERT-RPE1 cells (Figure 2-4 A). We then used a direct in vitro O-GlcNAcylation assay to 
examine how tubulin O-GlcNAcylation affects the stability of axonemal microtubules. HA-OGT 
was overexpressed in hTERT-RPE1 cells for 48 h, and then purified with anti-HA antibody 
attached to protein A beads. We then checked if the purified HA-OGT could catalyze O-
GlcNAcylation of axonemal microtubules in vitro, and if O-GlcNAcylation promoted axonemal 
microtubules disassembly (Figure 2-4 B1). The results showed that the amount of O-
GlcNAcylated α-tubulin increased in reactions added with HA-OGT, indicating α-tubulin is a 
substrate of OGT. Moreover, the amount of free -tubulin in the supernatants was increased 
compared to the reaction without HA-OGT. The supernatant contained a higher amount of 
disassembled free tubulin in reaction prolonged for 2 hours than for just 1 hour (Figure 2-4 B2). 
This result indicated that O-GlcNAcylation of -tubulin promoted disassociation of tubulin from 
axonemal microtubules.  
 
We reasoned since O-GlcNAcylation promoted axonemal microtubule disassembly, cilia 
undergoing disassembly were likely to have a higher level of O-GlcNAcylation. To test this 
prediction, we turned to a temperature sensitive flagellar mutant fla10ts of the green algae 
Chlamydomonas reinhardtii. The mutant fla10ts harbors a point mutation in the kinesin-II motor 
subunit FLA10, and is functionally normal in flagellar assembly at the permissive temperature 
(18°C) but abolishes the anterograde Intraflagellar transport (IFT) at the non-permissive 







240]. We checked the levels of protein O-GlcNAcylation in fla10ts flagella that were undergoing 
disassembly. The results showed that O-GlcNAcylation was increased in disassembly active 
flagella (Figure 2-4 C). 
 
Figure 2- 4 O-GlcNAc of -tubulin related to instability of flagellar axoneme. 
(A) Endogenous -tubulin was immune-precipated and subjected to IB with anti--tubulin and 
anti-O-GlcNAc antibodies. (B1) Purified HA-OGT was incubated with flagellar axonemes for 1 
h or 2 h. IB analysis showed the relative amounts of input reactants of HA-OGT (probed with 
anti-HA), axonemes (blotted with antibodies against -tubulin and acetylated-tubulin), and the 
base level of O-GlcNAc modification of axonemal microtubules (labeled as O-GlcNAc). (B2) 
After 1 h or 2 h, the supernatants and pellets were separated for IB analysis. (C) Flagella of 
fla10ts harvest after cells were incubated at 32C for 0, 0.5, 1, and 2 h were used for IB analysis. 
The levels of O-GlcNAc were increased in fla10ts flagella from cells incubated at 32C. The 



































   
  
   






   
   






























O-GlcNAcylation of HDAC6 involved in ciliary length shortening 
HDAC6 plays an important role in cilia assembly. Recent proteomic analysis shows that HDAC6 
is an O-GlcNAcylated protein [234]. It is possible that O-GlcNAcylation activates HDAC6 
deacetylase activity, which leads to cilia shortening. If this is true, we reasoned that ciliary 
shortening induced by elevated protein O-GlcNAcylation should be blocked by inhibition of 
HDAC6. To test this idea, the hTERT-RPE1 cells were treated with HDAC6 inhibitor Tubacin 
[241] or together with OGA inhibitor TG or SG (Figure 2-5 A). The ciliary length analysis 
showed that inhibition of HDAC6 activity indeed prevented cells from shortening caused by TG 
or SG treatment (Figure 2-5 B). This result suggested that the elevated HDAC6 deacetylase 









Figure 2- 5 Inhibition of HDAC6 suppressed ciliary resorption induced by TG or SG 
treatment. 
The hTERT-RPE1 cells were subjected to TG, SG, TG + Tubacin, SG + Tubacin, or control 
DMSO treatment. (A) Confocal images of cells co-immunostained with antibodies against 
acetylated tubulin and IFT88. Scale bar equals 5 m. (B) The mean length of cilia of cells with 
different treatments (*p < 0.05, **p < 0.01 (pTG = 0.001, pSG = 0.017, pTubacin = 0.97, pTG/Tubacin = 
0.8, pSG/Tubacin = 0.74)). Data are mean  SD. 
 
To examine the underlying mechanisms of how O-GlcNAcylation affected HDAC6, we first 
checked whether HDAC6 and OGT interacted in vivo. Immunoprecipitation using either anti-
HDAC6 or anti-OGT antibody confirmed that these two proteins could be co-immune-
precipitated reciprocally from lysates of hTERT-RPE1 cells (Figure 2-6 A). The immune-







spectrometry proteomic data [234]. Collectively, these results showed that HDAC6 was a 
substrate of OGT.  
 
O-GlcNAcylation could potentially increase the HDAC6 deacetylase activity by two means: 
increasing the protein amount, or increasing the actual enzymatic activity. We confirmed that the 
amount of HDAC6 protein was higher when O-GlcNAcylation was promoted by OGT 
overexpression (Figure 2-6 C), or by OGA inhibition (Figure 2-6 D). We then checked whether 
O-GlcNAcylation of HDAC6 affected its deacetylase activity (Figure 2-6 E). The HDAC6 
protein was Immune-precipitated from the lysates of hTERT-RPE1 cells treated with either TG 
or SG. Equal amounts of purified HDAC6 protein from cells with various treatments were 
incubated with axonemal microtubules purified from Chlamydomonas for 1 h at 37C. HDAC6 
from cells treated with TG or SG had a higher tubulin deacetylation activity compared to the 
protein from control cells. This result hinted that O-GlcNAc modification of HDAC6 enhanced 
its deacetylase activity. Taken together, the increased activity of HDAC6 in cells with high O-









Figure 2- 6 HDAC6 was O-GlcNAcylated and O-GlcNAc modification of HDAC6 enhanced 
its deacetylase activity. 
(A) Protein OGT and HDAC6 were reciprocally co-immune-precipitated together from cell 
lysates. IB analysis of HDAC6 and OGT in immune-precipitates using anti-HDAC6, anti-OGT, 
or control rabbit IgG. (B) HDAC6 protein was O-GlcNAcylated. HDAC6 protein was immune-
precipitated from cell lysates and then subjected to IB with antibodies against HDAC6 and O-
GlcNAc. (C) The amount of HDAC6 level in HA-OGT overexpression cells was increased. (D) 
The amount of HDAC6 immune-precipitated using the same amount of anti-HDAC6 antibody 
from TG or SG treated cell lysates was higher than that from the control treated with DMSO 
(Con) lysates. (E) The same amount of immunopurified HDAC6 proteins from TG or SG treated, 
or DMSO (control) cell lysates were used in Tubulin Deacetylase (TDAC) assays. After 
reactions were ended, the samples were subjected to IB to check the levels of indicated proteins. 
The levels of acetylated-tubulin were reduced in samples containing HDAC6 purified form TG 





























   
   








   
  
   





   
   












   
  
   






   
   








































O-GlcNAcylation of INPP5E did not affect its ciliary localization in hTERT-RPE1 
Inositol polyphosphate 5-phosphatase (INPP5E) is a ciliopathy disease protein involved in 
Joubert and MORM syndromes [242, 243]. INPP5E plays an important role in the stability of 
primary cilia through affecting the ciliary membrane lipid composition [244, 245]. Moreover, 
both HDAC6 and INPP5E are substrate of AurA kinase [246]. We asked whether INPP5E is O-
GlcNAcylated and whether its function is affected by O-GlcNAcylation. We first checked 
whether INPP5E was a substrate of OGT (Figure 2-7). INPP5E and OGT could be co-Immune-
precipitated reciprocally. INPP5E was O-GlcNAcylated, confirming it was a substrate of OGT 
(Figure 2-7 A&B). However, the amount of O-GlcNAcylated INPP5E did not change even when 
the overall O-GlcNAcylated protein amount increased with OGA inhibitor treatments (Figure 2-
7 C). Moreover, the ciliary localization of INPP5E appeared to be normal in either OGT loss or 








Figure 2- 7 O-GlcNAcylation of INPP5E does not affect ciliary localization in hTERT-
RPE1 cells. 
(A) Endogenous OGT was Immune-precipitated and subjected to IB with OGT and INPP5E 
antibodies. (B) Endogenous INPP5E was Immune-precipitated and subjected to IB with INPP5E 
and OGT antibodies. (C) INPP5E was O-GlcNAcylated. The hTERT-RPE1 cells were first 
treated with mock DMSO (Con), or OGA inhibitors TG or SG, to modulate intracellular O-
GlcNAc levels. Then the endogenous INPP5E was Immune-precipitated and subjected to IB with 
O-GlcNAc and INPP5E antibodies. (D) Representative confocal images of hTERT-RPE1 cells 
(siOGT treatment) immunostained with anti-INPP5E and anti-acetylated-tubulin antibodies. 
Scale bar equals 5 m. (E) Representative images of cells immunostained with anti-INPP5E and 
anti-acetylated- tubulin. The hTERT-RPE1 cells were transfected with HA-Vector or HA-OGT. 








This study uncovered a negative regulatory role of O-GlcNAcylation on primary ciliary length in 
both hTERT-RPE1 and IMCD3 cells. In OGT gain-of-function cells, ciliary length was 
shortened, while ciliary length was elongated in OGT loss-of-function cells. O-GlcNAcylation of 
-tubulin promoted its disassociation from the axoneme, which might promote the disassembly 
of axoneme. O-GlcNAcylation of HDAC6 activated its deacetylase activity to deacetylate 
axonemal microtubule, which was likely causing cilia to resorb. Based these results, we 
concluded that the ciliary length is sensitive to the cellular level of O-GlcNAc. We propose that 
the constant cross-talk between the primary cilium and O-GlcNAc is an important mechanism 
for cells fine-tuning the cellular responses to nutrients (Figure 2-8). 
 
Figure 2- 8 Molecular model of O-GlcNAc in regulating ciliary assembly and disassembly. 
When the cellular O-GlcNAc level is high, more axonemal -tubulin are O-GlcNAcylated. 
These tubulins disassociate from axonemal microtubules, which promotes axonemal 
disassembly. O-GlcNAcylation of HDAC6 also enhances its deacetylase activity, which leads to 
axonemal disassembly. Collectively, the ciliary length is shorter in a high O-GlcNAc cellular 
condition. Conversely, a low O-GlcNAc level stabilizes axonemal microtubules which allow 
longer cilia to assemble. Therefore, the cross- talk at the molecular level between O-GlcNAc and 







This study uncovers O-GlcNAc as an important input signal to ciliary assembly and function. 
Primary cilia act as a cellular ‘antenna’ that receives diverse signals from the extracellular 
environment, including chemical and mechanical stimuli. The past studies of a wide spectrum of 
human ciliopathies, for example, polycystic kidney disease, Bardet-Biedl syndrome and 
orofaciodigital syndrome [11, 225], demonstrate that the cilium is an essential organelle for 
almost every aspect of development and tissue homeostasis. The negative feedback regulation of 
ciliary length by the key nutrient sensor O-GlcNAc shown by this study appears to be a 
mechanism of sensory signal adaptation. The elongation of the cilium is to increase its signal 
detection when nutrients are scarce, while the resorption is to limit its responsiveness to external 
signals. By adjusting their size depending on the abundance of nutrients, cilia allow cells to tune 
out random nutrient flux fluctuations, and to upregulate or downregulate cilia sensitivity to 
nutritive environment. Obviously, the constant dialogue between cilia and O-GlcNAc is 
beneficial to maintain O-GlcNAc homeostasis, which is critical to many cellular processes 
including cell cycle progress, stress response, and gene transcription [247]. Disruptions in O-
GlcNAc homeostasis are proposed to lead to the development of diseases, such as cancer, 
diabetes, and Alzheimer’s disease [208, 247-250].  
 
A wide range of signals from cell cycle, protein synthesis, autophagy, and cytoskeletons not only 
rely on cilia to function, but also regulate the assembly and resorption of cilia [225]. For 
example, these pathways modulate the activity of HDAC6 [232], OFD1 [34], mTOR [251], 
GSK3 [252], or other enzymes and regulatory proteins that are important for the ciliogenesis 
[204]. However, very little is known on which one of the signaling proteins or messengers 







cilium length regulation. In this study, we showed that the level of protein O-GlcNAcylation 
negatively regulates the length of cilia. Since O-GlcNAcylation integrates multiple metabolites, 
such as carbohydrates, amino acids, fat and nucleotides, it is well-suited to tell the nutritive state 
of an organism. Future research is required to examine whether several ciliary signal inputs 
converge on O-GlcNAc to regulate ciliary length.   
 
Biochemical analysis of isolated flagella from Chlamydomonas showed many flagellar axonemal 
proteins were O-GlcNAcylated (Figure 2-4 C). Moreover, the overall O-GlcNAc level was much 
higher in flagella undergoing disassembly (Figure 2-4 C), supporting that upregulated O-GlcNAc 
leads to ciliary resorption. In this study we checked a couple of proteins with well-established 
functions in ciliogenesis on how their O-GlcNAcylation affects axonemal microtubules. 
Although INPP5E was O-GlcNAcylated, we failed to link this modification to its ciliary function 
(Figure 2-7). We found that O-GlcNAcylation of -tubulin promoted its disassociation from 
axonemal microtubules (Figure 2-4 B). The axonemal microtubules are heavily post-translational 
modified with acetylation, glycylation, and glutamylation [253]. Tubulin acetylation and 
glycylation stabilize axonemal microtubules. In contrast, polyglutamylation plays an opposite 
role, destabilizing axonemal microtubule [254, 255]. Here, we showed that O-GlcNAcylation is 
another MT destabilizer. Balanced tubulin post-translational modifications are important for 
ciliary length regulation. Future research on whether O-GlcNAcylation of tubulin coordinates 









In this study, we showed that HDAC6 was subjected to O-GlcNAcylation, and O-GlcNAc 
modification of HDAC6 promoted its enzymatic activity. HDAC6 is a key regulator of tubulin 
acetylation and functions in regulating MT stability [232]. The activation of HDAC6 involves its 
phosphorylation by Aur A kinase. Once activated, HDAC6 deacetylates acetylated MTs, leading 
to axonemal resorption. The mechanism of how O-GlcNAcylation of HDAC6 enhances its 
tubulin deacetylase activity is currently unknown. Since interplays between phosphorylation and 
O-GlcNAcylation are common, future research will be able to test whether O-GlcNAcylation of 
HDAC6 has a synergic effect on its phosphorylation, which in turn upregulates its activity.  
 
Methods and materials 
Cell culture  
The mammalian hTERT-RPE1 (ATCC CRL-4000) and IMCD3 (ATCC CRL-2123) cells were 
grown in DMEM-F12 (Gibco) supplemented with 10% FBS (Gibco) and 1% penicillin- 
streptomycin (Gibco) at 37 C in a 5% CO2 incubator. Cilia formation was induced by serum 
starvation for 24 h when cells reached 80% confluency.  
The Chlamydomonas wild type cc125 and fla10ts strains were obtained from the 
Chlamydomonas Center (http://chlamycollection.org/). Strains were cultured and maintained on 
Tris-acetate-phosphate (TAP) plates. Unless otherwise specified, liquid cultures used TAP media 
with constant aeration in a Conviron environmental chamber at 21°C with continuous light.  
 
Transfection  
Mammalian expression vectors pcDNA3.0-HA-OGT and pcDNA3.0-HA-OGT-rescue plasmids 







60% confluency. For each 10 cm Petri dish, cells were transfected with 5 g plasmids using the 
TurboFect transfection reagent (Thermo Scientific) and then cultured for 48 h before collected 
and prepared for immunoprecipitation (IP) using antibodies as indicated in the results part. For 
IF experiments, the hTERT-RPE1 cells were transfected with 1 g plasmids for each 3.5 cm 
Petri dish as described above. The IMCD3 cells were transfected with 1 g plasmids with 
Polyethylenimine (PEI) (Polysciences) reagent and then cultured for 48 h before used for IF 
analysis.  
 
RNA interference and inhibitor treatment  
The small RNA interference experiments were carried out using the same method as described in 
a prior publication. The transfection of the hTERT-RPE1 cells was carried out by using the 
LipofectamineTM RNAiMax Reagent (Invitrogen) according to the manufacture’s protocol. A 
mixture of two OGT oligonucleotides (siOGT 1# and siOGT 3#) at 1:1 ratio was used. All 
oligonucleotides including the control siGl2 (5’- CGUACGCGGAAUACUUCGAdTdT-3’) and 
the siOGT duplexes were synthesized by Dharmacon. 
 
The concentrations and durations of chemical inhibitor treatments used in all experiments were: 
TG (5 M, 24 h), SG (1 mM, 24 h), Alloxan (5 mM, 18 h), and Tubacin (2 M, 24 h). The 
solvent DMSO was used as control for each inhibitor treatments.  
 
Rescue with HA-OGT-rescue  
The hTERT-RPE1 cells were first transfected with the HA-OGT-rescue plasmid, or a control 







siGl2 or siOGT. After starving in DMEM for 24 h, the cells were harvested for immunoblotting 
(IB) or IF analysis (Figure 2-1 B).  
 
Immunoprecipitation (IP)  
For IP, cells were lysed with IP buffer (50 mM TrisCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 
0.5% NP40) supplemented with a Protease Inhibitor Cocktail (Roche). Lysates were incubated 
with protein A/G sepharose beads (Santa Cruz) for 2 h for pre-clearing of non-specific bindings  
prior to incubation with primary antibodies overnight at 4 C. The beads in the pellets were then 
subjected to IB analysis.  
  
Antibodies and immunoblotting (IB) assay  
Table S1 contains information of primary antibodies used in this study. The methods for SDS- 
PAGE and IB assays were the same as previous described. Chemiluminescence was used to 
detect the primary antibodies.  
 
Immunofluorescence staining  
Cells grown on glass coverslips were fixed with 4% paraformaldehyde for 10 min, followed by 
fixation in ice-cold methanol for 3 min. The cells were permeabilized with 1% Triton X-100 in 
PBS for 10 min before blocked in PBS with 3% BSA. Primary antibodies are listed in Table S1. 
Secondary antibodies of Alexa-488 and Alexa-561 were purchased from Invitrogen. Images were 
captured with an Olympus IX81 microscope (Olympus, Tokyo, Japan) with a Yokogawa CSU-








Flagella isolation and axoneme preparation  
Flagella were isolated as previously described [240]. Flagellar membrane was removed by 
incubating isolated flagella in 1% NP40 for 30 min on ice.  
 
Tubulin deacetylase (TDAC) assay  
Endogenous HDAC6 proteins were Immune-precipitated from lysates of hTERT-RPE1 cells 
treated with TG, SG, or control DMSO. The IPs by rabbit IgG and anti-HDAC6 (Con) from 
control treated cell lysates were used as negative controls. TDAC assays were carried out as 
previously described (Hubbert et al., 2002). Briefly, Chlamydomonas flagella axonemes (~ 40 
μg) and HDAC6 were incubated together in 200 l TDAC buffer (20 mM Tris-Cl pH 8.0, 20 
mM NaCl) at 37 C for 2 h, and then transferred to ice for 15 mins. Pellets containing protein-A 
beads were collected by centrifugation. The pellets were analyzed by IB with anti-HDAC6 
antibody and the supernatants were analyzed with anti--tubulin and anti-acetylated-tubulin 
antibodies.  
 
In vitro tubulin O-GlcNAcylation assay The in vitro tubulin O-GlcNAcylation assays were 
performed as described previously [256] with minor modifications. HA-OGT expressed in 
hTERT-RPE1 cells was purified by IP using anti-HA antibody. The reaction mixture for in vitro 
glycosylation contained 50mM TrisCl, pH 8.0, 5 mM MgCl2, 2 mg HA-OGT, 6 l flagella 
axonemes, and 1 mM of UDP- GlcNAc (Sigma-Aldrich) in a reaction volume of 50 μl. The 
reactions were performed at 25 C for 1 h or 2 h. The axonemes and beads were collected by 
centrifugation. Both the pellets and the supernatants were analyzed by IB with antibodies 







Percentages of ciliated cells and ciliary length measurements  
For counting the percentages of ciliated cells, only the cells clearly IF stained by antibodies 
against acetylated-tubulin and IFT88 were considered as ciliated. No less than 150 random 
selected cells combined from three independent experiments were used. The IF staining of IFT88 
was used to measure the ciliary length since the staining clearly marked the base and the tip of a 
cilium. The segmented line selection tool of Image J (Java 1.8.0_172, https://imagej.nih.gov/ij) 
was used for length measurements. For all ciliary length measurements, 150 cilia combined from 
three independent experiments were used for statistical analysis.  
 
Statistical analysis   
Statistical analyses were performed using the software GraphPad Prism 7.0e (GraphPad 
software, San Diego, California, USA). Results were shown as mean standard deviation. 
Statistical analyses between two groups were performed using the student’s t-test. p-value less 
than 0.5 was considered significant. The mark “*” represents p<0.05, **represents p<0.01, and 









EXPLORING THE FLAGELLA AXONEME OF CHLAYMYDOMONAS REINHARDTII AS A 
PROTEIN SYNTHESIS PLATFORM 
 
Introduction 
Biosynthesis is a multi-step enzymatic intracellular process to produce complex products in 
living organisms. Biosynthetic pathways typically use monomers as building blocks to build 
macromolecules, such as proteins, nucleotides, and lipid membrane components. Proteins, one of 
the essential components in all organisms, have multiple functions such as enzyme catalysis, 
immune-defense, transport/storage, and regulation. Given the important function of proteins, 
they have been studied intensively and applied widely in medicine, research, and biotechnology. 
With the desire for increased protein production, multiple biotechnological methods have been 
developed [257]. The typical one is the recombinant molecular biology. Briefly, the gene 
encoding a specific protein is cloned into an expression vector then the vector transformed into a 
system that expresses the protein. Expression systems include, but are not limited to, bacteria, 
yeast, insects, and mammalian cells [258-260]. There are tremendous advantages to using 
organisms as an expression system, such as allowing bacteria to quickly produce a large number 
of proteins to determine protein structures; yeast to produce proteins with significant PTMs; and 
insect and mammalian cell lines to execute mRNA splicing similar to human cells. However, 
there are some limitations when considering the function and quality of the target protein. For 
example, bacteria often express non-functional proteins or insoluble proteins in inclusion bodies 
due to misfolding; eukaryotic expression systems like mammalian cells have very low yield, the 







unicellular green alga Chlamydomonas reinhardtii is an ideal protein production system because 
it can provide high yield and mathematically calculated products. Other advantages include easy 
isolation of flagella, stability during storage, and low cost. Thus, the flagella axoneme is an ideal 
platform for constructing protein arrays. 
 
Chlamydomonas flagella are motile structures that extend from the anterior surface. Flagella are 
composed of a microtubule-based axoneme underneath an extended plasma membrane. The 
axoneme consists of nine doublet microtubules (DMTs) surrounding one pair of singlet 
microtubules with multiple appendage structures attached to render flagella motility, such as 
radial spokes, inner and outer dynein arms, and nexin. The appendage structures’ components 
and arrangement on the axoneme are well studied. The axoneme is about 12 m long and the 
structural components are repeated every 96 nm on the axoneme [262]. For instance, radial spoke 
is a T-shaped complex and contains a stalk and a head that is composed of at least 23 proteins. 
The stalk is anchored to the doublet microtubules and globular head toward the central pair of 
singlet microtubules, the connection between these two gives the mechanical movement of the 
flagella. In each of 96 nm periodic structure, there are two complete radial spokes and one 
truncated spoke [263]. The inner junction is a bridge structure between A- and B-tubules of the 
doublet microtubules, which is formed by a smaller subunit of non-tubulin proteins. FAP20 is 
one protein of the inner junction and plays a role in the symmetrical waveform of the flagella. 
FAP20 localizes along the entire length of the axoneme, and there are 12 or 24 FAP20 molecules 








Because protein synthesis can only happen in the cytoplasm, flagellar proteins are transported 
and assembled on the axoneme by the molecular machinery named intraflagellar transport (IFT). 
The IFT recognizes flagellar proteins then transports them into the flagella compartment and 
incorporates them onto the appropriate positions of the axoneme. This unique structure and self-
assembly mechanism of flagella axoneme makes it an excellent template to assemble an 
exogenous protein array. It can be achieved by expressing a construct that contains a fusion gene 
of an axoneme protein and an exogenous protein in the cytoplasm. The axoneme protein can 
serve as an adaptor to carry the exogenous protein onto the axoneme.  
 
The availability of using flagellar axoneme as a protein self-assembly scaffold is supported in 
several ways. First, the genome and flagella proteome of Chlamydomonas are entirely 
sequenced. Therefore, it is approachable to do any genetic modifications to express the fusion 
construct. Second, there are many axoneme protein null mutant strains available, which allows 
fusion proteins to be expressed and incorporated into the axoneme without the endogenous 
protein. Third, there are many examples in which tagged axoneme proteins have been 
successfully expressed and assembled on the axoneme and rescued the phenotypes of the mutant 
strains, such as HA, GFP, and BCCP tagged axoneme proteins FAP20 and RSP3 [201]. In 
addition, transformants can be identified quickly by observing their swimming motility. This is 
because appendage structures are necessary for flagella motility, but adaptor-null mutants are 
usually non-motile. When the fusion protein is expressed and incorporated onto the axoneme, 








Simultaneously, flagella axoneme serves as a protein production template, which benefits from 
all advantages of the natural assembly attributes. First, flagella are easily isolated and produced 
in large quantities. Chlamydomonas cells have two flagella and are easy to grow on a large scale 
at low cost. Flagella are easily detached from the cell body by lowering pH to 4.5 then isolated 
by centrifugation. The target protein anchored to the axoneme as a whole can serve as an 
immobilized enzyme, or the target protein can be released from the axoneme by protease 
cleavage. Second, the target protein should be arranged on the axoneme in a high density and 
periodic manner due to the fusion with an axoneme protein, and the yield of the products can be 
calculated. Furthermore, the target protein yield can be increased by flagella regeneration. After 
flagella are detached, cell bodies can regenerate full-length flagella within two hours and the 
regeneration can repeat multiple times. Finally, isolated flagella are stable and easily stored. 
Because no protease exists in the flagellar compartment, proteins would not be degraded and 
protein activity is therefore stable. 
 
Here we investigated using axoneme proteins FAP20 and RSP3 as adaptors to transport and 
incorporate target proteins to the axoneme. These two adaptors were chosen to take advantage of 
existing FAP20 and RSP3 null mutant strains im5 and pf14, as well as rescue constructs pBS-
FAP20-GFP and pKF-RSP3-GFP. Also, the spatial patterns of FAP20 and RSP3 on the axoneme 
are clear, which enables estimates of target protein yield. To test the hypothesis of using flagella 
axoneme as a biosynthetic template, we first modified the rescue constructs to express fusion 
proteins. The GFP gene in the original rescue constructs pBS-FAP20-GFP and pKF-RSP3-GFP 
was replaced with the target protein gene estrogen receptor alpha (ER) or beta-lactamase (Bla), 







linker was added to connect the adaptor and the target protein genes. Second, the fusion 
constructs were transformed to the mutant strains im5 and pf14, and the transformants were 
identified based on the rescue of swimming motility and confirmed by WB. Furthermore, 
flagella were purified to test the target protein enzymatic activity and stability. Ultimately, we 
demonstrated that fusion proteins assembled on the axoneme and rescued the phenotype of the 
mutant strains. Furthermore, target protein yield can be increased by flagellar regeneration. 
Finally, axoneme-anchored target proteins were enzymatically active and were resistant to 
freeze-thaw treatment. This study provides a key fundamental step towards the development of 
using flagellar axoneme as a protein self-assembly template. 
 
Results 
Designing the of use of flagellar axoneme as a template to dock the protein of interest  
The axoneme proteins FAP20 and RSP3 were chosen as adaptor proteins to transport target 
proteins for two reasons. First, we have FAP20-loss-of-function mutant strain im5 and RSP3-
deficient mutant strain pf14 on hand, as well as their rescue constructs of pBS-FAP20-GFP and 
pKF-RSP3-GFP [201]. Both constructs can rescue the expression of FAP20 and RSP3 to WT 
levels. The FAP20-GFP fluorescence intensity is three times that of RSP3-GFP, which indicates 
three times more FAP20 on the axoneme than RSP3. Also, the rescued strains recovered 
axoneme motility, which indicates that the GFP tag does not affect the adaptor protein function 
[201]. 
 
We modified the rescue constructs by substituting the GFP gene with the target protein gene in 







deleted. In the pKF-RSP3-GFP construct, the C-terminal 140 amino acids of RSP3 were also 
deleted to generate more space for the target protein because the last 140 amino acids of RSP3 
do not affect either recruitment of radial spoke proteins assembled on the axoneme or the 
motility of flagella [199] (Figure 3-1 A&B). Furthermore, the target protein genes following the 
TEV linker were inserted behind the adaptor protein gene. The target protein can be released 
from the axoneme by TEV enzyme digestion (Figure 3-1 C&D). In the rescued strains, the fusion 
protein should be arranged on the axoneme in a high density and periodic manner, and the yield 
of the fusion protein can be calculated precisely based on the arrangement of the adaptor protein 
(Figure 3-1 E). 
 
Figure 3- 1 Design of applying flagellar axoneme as a biosynthetic template. 
(A) The construct of pBS-FAP20-GFP and pKF-RSP3-GFP were modified to express the fusion 
proteins of FAP20/RSP3 and the target protein. The fusion proteins were connected by a TEV-
linker. The EcoRV-linker and GFP gene were deleted in both of the original constructs of pBS-
FAP20-GFP and pKF-RSP3-GFP. In addition, the C-terminal 140 amino acids of RSP3 were 
deleted as well in the pKF-RSP3-GFP construct. Then replaced with a TEV-linker and the target 
gene. (B) The schematic structure of flagella axoneme showed the expression of the fusion 
proteins. The target protein is fused with an axoneme protein, such as FAP20 and RSP3. The 
axoneme protein is serving as an adaptor to transport and locate the target protein onto the 












Prescreening of rescued strains based on the phenotype of motility and flagellar assembly 
To increase the potential of the fusion proteins assembled on the axoneme, we chose two small 
target proteins, the ligand-binding domain of estrogen receptor alpha (ERLBD) and beta-
lactamase (Bla). Both proteins are of a similar molecular weight as GFP (~ 30 kD). Also, the 
substrates of both target proteins are hydrophobic so can easily pass through the flagellar 
membrane. Therefore, it is possible to test the target protein enzymatic activity without removing 
the flagellar membrane.  
 
The rescue constructs that express fusion proteins include: pBS-FAP20-TEV-ERLBD, pBS-
FAP20-TEV-Bla, pKF-RSP3-TEV-ERLBD, and pKF-RSP3-TEV-Bla (shortened as FAP20-
ER, RSP3-ER, FAP20-Bla, and RSP3-Bla). The constructs of FAP20-ER and FAP20-Bla 
were transformed into the im5 strain, and RSP3-ER, RSP3-Bla were transformed into the pf14 
strain. Because both im5 and pf14 strains have defects in swimming motility and flagellar 
assembly, it was efficient to identify the transformants based on their motility and flagellar 
assembly. All antibiotic-resistant colonies achieved on the TAP plate after transformation were 
transferred to a 96-well plate with a liquid TAP medium and cultured with continuous light. 
Then cell motility was checked under a light microscope after a 1-day culture. The motile cells 
were transferred to a test tube with 3 ml TAP medium and cultured for another two days to 
ensure motility and flagellar assembly (The flagellar assembly results are not listed here) (Figure 
3-2). The movies are included as separate files. The expression of the target protein in the 









Figure 3- 2 Swimming motility of various strains. 
Swimming motility of WT strain cc125, mutant strains im5 and pf14, and rescues strains FAP20-
ER, Bla and RSP3-ER, Bla were taken in real time. 
 
Confirming the positive transformed strains by WB 
To confirm the expression of the fusion proteins in the transformants I wanted to use WB. To 
increase sensitivity, flagella from all transformants with swimming motility were isolated and 
prepared for WB. We got five flagella samples of FAP20-ER 6, 9, 12, 13, and 14; and five 
flagella samples of RSP3-ER 7, 9, 10, 11, and 14. All samples were subjected to WB. The IB 
results of ER showed that the expression levels of ER protein varied significantly in all 
flagella samples. FAP20-ER 12, 14 have relatively higher ER expression levels compared to 
others, and RSP3-ER 10 is the only one with the ER expression. To further confirm the 
expression of the fusion protein, flagella samples were immune-blotted with anti-axoneme 
protein antibodies FAP20 and RSP1. Because of the deletion of 140 amino acids at the C-
terminal, RSP3 antibody would not recognize the truncated RSP3. However, the other radial 
spoke proteins, such as RSP1, can only present when expression of RSP3 is rescued. Therefore, 







showed that FAP20 is expressed in the rescue strains, but the protein level is much lower than in 
WT. In contrast, the expression of RSP1 was close to WT levels in all flagella samples. These 
results indicated that the target protein is restricted to the flagellar compartment (Figure 3-3 
A&C). Here, FAP20-TEV-ER 14 and RSP3-TEV-ER 10 were chosen as the rescued strains. 
 
In parallel, we obtained four samples of FAP20-Bla 2, 3, 4, and 5; and five samples of RSP3-Bla 
7, 8, 9, 10, and 11. The immune-blotting (IB) results of Bla showed that beta-lactamase was 
expressed in FAP20-Bla sample 4 and all samples of RSP3-Bla. The IB results of FAP20 and 
RSP1 showed that the expression of FAP20 is still much lower in the rescued strain than the WT, 
while RSP1 expression levels are equivalent to WT (Figure 3-3 B&D). Here, FAP20-Bla 4 and 
RSP3-Bla 10 were chosen as the rescued strains. 
 
Flagellar length was also measured in each of the rescued strains. WT cells had average flagellar 
length of 13.4 m; whereas the mutant cells of im5 and pf14 had lengths of 10 m and 8.2 m, 
respectively, which indicated their flagellar assembly defects. These defects were recovered in 
the rescue strains. The FAP20-ER 14 and FAP20-Bla 4 assembled the flagellar length of 13.1 
m and 10.7 m, RSP3-ER 10 and RSP3-Bla 10 assembled flagellar length of 13.5 m and 










Figure 3- 3 Confirmation of the rescued strains from the candidates of prescreening. 
(A-D) Flagella samples were prepared from each of the transformants with swimming motility, 
and WT used as a negative control. All samples were subjected to WB. The FAP20-ER and 
RSP3-ER samples were blotted with ER, FAP20, and RSP1 antibodies to detect the 
expression of both the axoneme protein and the target protein. The FAP20-TEV-Bla and RSP3-
TEV-Bla samples were blotted with beta-lactamase, FAP20, and RSP1 antibodies to detect the 
expression of the fusion proteins. The final candidates for each transform were chosen based on 
the expression of the axoneme protein and the target protein. (E) The pictures of cc125 and the 
rescued strains showed the assembly of flagella. Error bar equals 10 m. (F) The statistical 
results showed the flagellar length in each of control strains, cc125, im5, and pf14, and the 
rescued strains, FAP20-ER 14, Bla 4 and RSP3-ER 10, Bla 10. The error bar showed the 

















































Figure 3-3 Continued. 
 
Quantifying the expression of the target proteins 
After confirming the rescue strains, I purified flagella to test the enzymatic activity of the target 
proteins. FAP20-ER and RSP3-ER as one group will be discussed first. FAP20-Bla and 
RSP3-TEV-Bla as another group will be discussed later. WT, FAP20-ER, and RSP3-ER 
strains were cultured in 4 L TAP medidum to get enough flagella for conducting ER binding 
assay. Flagella were harvested as described, and an equal volume of flagella from each sample 
was used to prepare samples for protein level quantification. Standard BSA concentration 
samples were used as a reference, and the quantification results showed that the acetylate-tubulin 
concentration of WT, FAP20-ER, and RSP3-ER samples was 2.4 g/l, 0.8 g/l, and 1.45 
g/l, respectively (Figure 3-4 A). To ensure the equal amount of the flagella in the following 
binding assay, the concentration of all samples was adjusted to 0.8 g/l then subjected to WB. 
The IB results showed that the expression of ER in the FAP20-ER is about 2.4 times of the 
RSP3-ER, and acetylate-tubulin was used as a loading control (Figure 3-4 B). The result is 









Figure 3- 4 FAP20-ER and RSP3-ER flagella isolation and quantification.  
(A) Coomassie blue staining showed the intensity of BSA standard samples and WT, FAP20-
ER and RSP3-ER flagella samples. The quantification results by measuring the main band 
intensity showed the concentration of flagella samples are 2.4 g/l, 0.8 g/l, and 1.45 g/l 
separately. (B) The concentration of flagella samples was adjusted to 1 g/l with the dilution of 
HMDEK buffer and subjected to WB. The IB of ER showed the protein expression levels in 
each of the flagella samples and IB of acetylate-tubulin showed the equal loading of each 
sample. 
 
Analyzing the ability of FAP20-ER and RSP3-ER flagella to bind to estrogen compounds 
To test whether axoneme-tethered ER can bind to estrogenic compounds, the system of S. 
cerevisiae BLYES was applied to detect the existence and concentration of estrogen compounds. 
In principle, estrogen compounds will bind to the human estrogen receptor (hER) and initiate 
the transcription of estrogen response element (ERE) followed by the expression of a 
bioluminescent bioreporter gene. All three genes were expressed in S. cerevisiae. The 
bioluminescent intensity positively correlates to the concentration of estrogen compounds [264]. 







binding assay. The concentration of 17- estradiol was measured before and after incubation 
with flagella samples. The concentration reduction can reflect the flagella affinity for estrogen 
compounds. 
 
A standard curve was built first to indicate the relationship between the concentration of 17- 
estradiol and bioluminescent. The BLYES system can detect substrate concentration from 10-9 M 
to 10-5 M. The 50% effective concentration (EC50) value is around 10-7 M and this was used as 
the starting concentration in the following binding assays. All three flagella samples of WT, 
FAP20-ER, and RSP3-ER were incubated with 10-7 M 17- estradiol in a total 5 ml volume 
system. At the time points of 1, 3, 6, 24, and 48 hours, 800 l reactants were taken to measure 
the 17- estradiol concentration using the BLYES system (Figure 3-5). The results showed that 
WT flagella, a negative control, decreased 26% of 17- estradiol, while FAP20-ER and RSP3-
ER flagella decreased 17- estradiol by 47% and 39% separately after incubation of 48 hours. 
The results indicate that the target protein ER on the axoneme of FAP20-ER and RSP3-ER 









Figure 3- 5 FAP20-TEV-ER and RSP3-TEV-ER flagella ER binding assay. 
200 l each of WT, FAP20-TEV-ER, and RSP3-TEV-ER flagella were incubated with 10-7 M 
17--estradiol in a total volume of 5 ml system. 800 l reactants were taken out to conduct the 
BLYES assay at the incubation time points of 1, 3, 6, 24, 48 hours. The bio-luminance at each 
time points were measured. The decreased bio-luminance indicates the binding amount of 17--
estradiol to flagella. 
 
Regenerating of FAP20-TEV-Bla and RSP3-TEV-Bla flagella  
One advantage of using flagellar axoneme as a biosynthetic template is that the yield of products 
can be easily accumulated by flagella regeneration. We used WT, FAP20-Bla, and RSP3-Bla 
strains to test the yield accumulation by flagellar regeneration. The original flagella were 
detached by lowering pH to 4.5, then separated from cell bodies by gentle centrifugation. The 
flagella in the supernatant were further concentrated by sucrose underlaying as described in the 
method. The cell bodies were resuspended in HEPES buffer and cultured for another 2 hours to 
regenerate flagella. Cell status and flagellar assembly were checked before harvesting the 
regenerated flagella. Due to the different flagellar regeneration time, FAP20-Bla flagella were 
only regenerated once, and RSP3-Bla flagella were regenerated twice. All original and 
regenerated flagella samples were observed under a light microscope, and flagellar lengths were 







original and regenerated flagella were 10.8 m and 11.1 m; the lengths of RSP3-Bla original, 
1st, and 2nd time regenerated flagella were 12.5 m, 11.6 m, and 12.1m (Figure 3-6 B). 
Overall, the lengths of original and regenerated flagella were consistent. 
 
Figure 3- 6 Isolation of FAP20-Bla and RSP3-Bla original and regenerated flagella. 
(A) Chlamydomonas strains of WT, FAP20-Bla and RSP3-Bla were cultured in the 4 L bubbly 
system. Cells were collected for flagella isolation when the concentration reached 106/ml. 
Original flagella were detached from the cell body by lowering pH to 4.5 transiently then 
bringing back to pH 7.0. The flagella and cell bodies can be separated easily by gently 
centrifuging at 2000 rpm. The flagella can be purified according to the protocol as described, and 
cell bodies were suspended and cultured in HEPES buffer to regenerate flagella. Then the 
regenerated flagella were collected in the same way. The pictures showed the purified flagella 
under 100x of a light microscope. Scale bar equals 10 m. (B) The statistical results showed the 
flagellar length in each of the strains. The error bar showed the flagella length deviation. About 
60 flagella were measured for each of the samples. 
 
Quantifying protein levels of FAP20-Bla and RSP3-Bla original and regenerated flagella  
The protein concentration of all flagella samples was quantified by comparing to BSA standard 
samples. The concentration of WT, FAP20-Bla original, regenerated, RSP3-Bla original, 1st, and 
2nd time regenerated flagella was 3.2 g/l, 2.2 g/l, 2 g/l, 4 g/l, 3 g/l, and 3 g/l, 
respectively. (Figure 3-7 A). The concentration of each sample was adjusted to 1.6 g/l and 







protein level of Bla in FAP20-Bla flagella is approximately 1.5 times that of RSP3-Bla (Figure 
3-7 B). However, the Bla protein levels were similar in each of the original and the regenerated 
flagella samples, which indicate that the yield of the product can be accumulated by flagella 
regeneration. 
 
Figure 3- 7 FAP20-TEV-Bla and RSP3-TEV-Bla flagella isolation and quantification. 
(A) Coomassie blue staining showed the intensity of BSA standard samples and RSP3-TEV-Bla 
original, 1st, 2nd regenerated flagella, FAP20-TEV-Bla original, regenerated flagella and WT 
flagella samples. The quantification results by measuring the main band intensity showed the 
flagella samples’ concentrations are 4 g/l, 3 g/l, 3 g/l, 2.2 g/l, 2 g/l and 3.2 g/l 
separately. (B) The concentration of flagella samples was adjusted to 1.6 g/l with the dilution 
of HMDEK buffer and subjected to WB. The IB of beta-lactamase showed the protein 
expression levels in each of the flagella samples and IB of acetylate-tubulin showed the equal 
loading of each sample. 
 
Detecting and quantifying Bla enzyme activity 
The activity of beta-lactamase was detected using the colorimetric Beta Lactamase Activity 
Assay Kit (ab197008). The assay is based on the enzymatic hydrolysis of the substrate nitrocefin, 
which results in the generation of a colored product that is detected by absorbance at OD 490nm 







standard curve was built to show the proportion between the concentration of the product and 
Abs 490nm, standard line equation is y=0.0185x + 0.0318 (Figure 3-8 A). Theoretically, 1 Unit 
Beta-Lactamase activity is defined as the amount of enzyme that generates 1.0 mol of nitrocefin 
per minutes at pH 7.0 at 25C. Sample Beta-Lactamase activity can also be expressed as mU/g, 
which means nmol/min hydrolyzed nitrocefin generated per g of protein. Based on the amount 
of hydrolyzed nitrocefin produced per minutes, the enzyme activity of Bla flagella can be 
calculated.  
 
For each of the original and regenerated flagella samples, I did two parallel assays of Bla activity 
by adding 5 l flagella for each test, then measured the absorbance at OD 490nm every minute 
for overall 20 minutes. Then calculate the enzymatic activity. The results showed that all FAP20-
Bla and RSP3-Bla original and regenerated flagella have Bla enzymatic activity (Figure 3-8 B). 
 
 
Figure 3- 8 FAP20-Bla and RSP3-Bla flagella beta-lactamase enzymatic activity assay. 
(A) A standard curve of enzymatic activity and absorbance at OD 490 nm. (B) Flagella samples 
were subjected to beta-lactamase activity assay. For each sample, 5 l flagella were added and 
incubated with 40 nM Nitrocefin in 100 l system and measured the absorbance of 490 every 










Analyzing the enzymatic activity of recycled flagella 
One advantage of the fixed enzyme is that the enzyme can be isolated from the reactants 
compared to soluble enzymes. Therefore, we want to know whether Bla flagella can be recycled 
to catalyze a new reaction. The flagella from the reactions were isolated by centrifuging at the 
maximum speed, 10,000 rpm for 10 minutes. The flagella were washed twice with 1x HMDEK 
buffer to remove the chemicals attached to the flagella. Then the flagella were subjected to a new 
reaction. The results showed that recycled flagella still have enzymatic activity but with subtle 
decreased (Figure 3-9). This may be caused by the flagella lost during the washing or the 
substrate from the previous reaction attached to the flagella. 
 
 
Figure 3- 9 Recycled flagella are still enzymatically active. 
The flagella from the first reaction were collected and re-subjected to a new reaction. The 
absorbance of 490nm were measured and calculate the enzyme activity. Two replicates were 











































The Bla flagella enzyme is resistant to freeze-thaw treatment and durable at room 
temperature, but is heat sensitive 
We showed that both FAP20-Bla and RSP3-Bla flagella express Bla with enzyme activity and 
flagella axoneme is a suitable enzyme carrier that can be recycled and regenerated. Now we want 
to know whether the enzyme tethering to the axoneme can have more properties compared to the 
soluble enzyme, such as higher catalytic efficiency and more stability during storage. First, we 
compared the catalytic efficiency between the commercial beta-lactamase enzyme and FAP20-
Bla and RSP3-Bla flagella. Either 5 l of commercial enzyme or flagella were added to the 
reaction system, and the kinetics were recorded within 20 minutes. Furthermore, because the 
commercial enzyme is usually sensitive to repetitive freeze and thaw, we want to test whether the 
fixed enzyme is resistant to freeze-thaw treatment. Therefore, we freeze-thaw both the 
commercial enzyme and flagella four times between -20 C and 20 C, then test the enzymatic 
activity with the same set up as before. The results showed that freeze-thaw treatment 
significantly decreased the commercial enzymatic activity about 32%, while both the flagella 
bound enzyme FAP20-Bla and RSP3-Bla have almost the same enzymatic activity compared to 
the un-treatment control (Figure 3-10). The results strongly indicate that the fixed enzyme is 
more resistant to the significant temperature change of freeze-thaw. Inspired by the results, we 
boiled the enzymes at 42C for 10 min to test whether the fixed enzymes are more heat stable. 
However, the results showed the opposite results as expected. Commercial Bla enzymatic 
activity only decreased by about 8.3% while the FAP20-Bla and RSP3-Bla enzymatic activity 
were decreased by 50.5% and 23%, separately (Figure 3-10). Even though the flagella 
cooperated enzymes are freeze-thaw resistance, their activity is easily denatured at a higher 







enzyme’s stability then measured the enzymatic activity. The result showed that the enzymatic 
activity of the fixed enzyme maintained the same as untreated controls after 48 hours, the 
commercial enzyme showed slightly decreased enzymatic activity about 3.2% (Figure 3-10). 
Overall, the results suggest that the fixed enzymes are more stable below the denature 
temperature, especially the fixed enzyme is resistant to freeze-thaw treatment. 
 
Figure 3- 10 Flagella enzymatic activity assay under different treatments. 
Standard Bla enzyme, FAP20-Bla and RSP3-Bla flagella were freeze-thaw for 4 times between -
20 and 20C, boil 10 mins at 42C, or kept at room temperature for 48 hours. 5 l commercial 
beta-lactamase enzyme and flagella from each sample were subjected to beta-lactamase activity 
assay. The untreated fresh samples were used as a positive control. The graph showed the 
enzyme activity. Two replicates were performed for the enzymatic activity assay.  
 
Discussion 
In this study, we showed the designing the Chlamydomonas flagellar axoneme as a biosynthetic 
template to synthesize enzymatically active biomolecules. The constructs of pBS-FAP20-TEV-
ER, pBS-FAP20-Bla and pKF-RSP3-TEV-ER, pKF-RSP3-TEV-Bla were made to express 





































































































and RPS3 are transported into the flagella compartment specifically by the IFT. Simultaneously, 
the target proteins of ER and Bla should be transported together at the time. Indeed, our results 
showed that target proteins are successfully expressed in the rescued strains and localized to the 
axoneme. Also, the target protein ER and Bla showed a similar expression ratio of the axoneme 
proteins FAP20 and RSP3, which indicate the high incorporation efficiency of the target protein 
to the axoneme. Further studies showed that target proteins ER and Bla are both enzymatically 
active. In the ER binding assay, FAP20-ER and RSP3-ER flagella showed a 30% decrease 
of the ER binding chemical after the incubation, while WT flagella did not show any affinity to 
the ER binding chemical. The results of beta-lactamase activity assay showed all original and 
regenerated flagella samples of FAP20-Bla and RSP3-Bla are enzymatically active, and they are 
more resistant to freeze-thaw treatment compared to the commercial soluble beta-lactamase 
enzyme. 
 
Compared to other models for synthesizing biomolecules, the application of using flagella 
axoneme as a biosynthetic template is unique in several aspects. First, the target protein 
assembled on the axoneme happened automatically and in a high density. Because the axoneme 
assembly is a cellular process that happened naturally, the target protein could self-assemble on 
the axoneme only if the construct carrying the gene of fusion protein expressed appropriately. 
Second, the components and arrangement of the axoneme structure are well studied. Therefore, 
the number of target proteins on a single axoneme can be calculated precisely, which should be 
the same as the adaptor protein. Third, the isolation of flagella is much easier compared to other 
systems. Since the target protein has already incorporated into the axoneme, to acquire the 







from cell bodies when the pH was lowered to 4.5 and purified by sucrose concentration gradient 
centrifugation due to different sediment of flagella and cell bodies. Unlike other systems, either 
the target proteins need to be purified from intracellular or need to be linked into the scaffold. 
Fourth, the regeneration of the flagella increases the yield of the target protein. Instead of 
increasing culture volume, flagella can repeatedly undergo deflagellation and regeneration for 
several cycles to accumulate the final products as showed by FAP20-Bla and RPS3-Bla flagellar 
regeneration. The regeneration can be done within 2 hours. Also, the flagella samples do not 
need to be collected every time. Because there is no protease in the flagella, there is no need to 
worry proteases will degrade the axoneme proteins. Flagella from multi-regeneration can be 
harvested together. Last but not least, flagella are easily stored, and their stability is maintained. 
Flagella kept at -20C are stable for several months. Also, axoneme anchored enzymes are more 
stable compared to the soluble enzymes. The fixed enzyme almost has the same enzymatic 
activity after multiple freeze-thaw treatments, while the soluble enzyme decreased activity by 
40%. Even leaving the flagella at RT for 48 hours, the enzymatic activity stays the same. 
 
In the ER binding assay, our results showed that both FAP20-ER and RSP3-ER flagella 
bind and remove about 30% of 17--estradiol in the solution. However, the binding efficiency of 
FAP20-ER is lower than the RSP3-ER (Figure 3-4), even though the WB results showed that 
FAP20-ER has protein levels two times more than RSP3-ER in an equal amount of flagella 
samples (Figure 3-5 C-D). The phenomenon indicates that axoneme ER may have already 
bound to estrogen compounds that existed in the medium. It makes sense because FAP20-ER 
protein density is higher in a single axoneme than RSP3-ER. Therefore, FAP20-ER binds 







ER binding assay. In the future, in order to increase the binding efficiency, the original flagella 
should be discarded and regenerated flagella in the pure HEPES buffer may help. 
 
Furthermore, our results showed that both the original and regenerated flagella of FAP20-Bla 
and RSP3-Bla have the same target protein expression levels and enzymatic activity, which 
support our hypothesis that flagella regeneration increases the yield of the target proteins. 
However, the small volume of flagella makes it harder to calculate the flagella number per 
microliter. We can only estimate the enzyme activity based on the amount of the products 
catalyzed by flagella samples. Theoretically, 1 Unit Beta-Lactamase activity is defined as the 
amount of enzyme that generates 1.0 mol of nitrocefin per minutes at pH 7.0 at 25C. Sample 
Beta-Lactamase activity can also be expressed as mU/mg, which means nmol/min hydrolyzed 
nitrocefine generated per mg of protein. Based on the standard line equation y=0.0185x + 
0.0318, when the A490nm equals 0.5, the hydrolyzed nitrocefine amount is 25.3nM. The enzyme 
activity of Bla in flagella amount of 5l reactions is around 250mU/mg (Figure 3-8 B). The 
enzyme activity of positive control soluble enzyme is around 1600mU/mg (Figure 3-10 B). The 
huge activity difference between the fixed enzyme and the soluble enzyme are mainly due to two 
reasons. One reason is that the flagella resuspension buffer HMDEK generates a huge 
background of 0.35, which disables the flagella to catalyze all substrate. The other reason is that 
the existence of flagella membrane dampens the turnover efficiency of substrate and products, 
even though nitrocefin is a hydrophobic molecule that can easily pass through the membrane. 
The improvements would be re-suspend flagella axoneme in beta-lactamase assay buffer for the 








In addition, the axoneme anchored enzyme is more resistant to freeze-thaw treatment. We did 
several temperature variables to test the stability of the fixed enzyme compared to the soluble 
enzyme. Because soluble enzymes are susceptible to freeze-thaw, one variable we chose is 
freeze-thaw enzymes for four times then measure the enzyme activity. The results showed that 
the fixed enzyme is resistant to freeze-thaw compared to the control. However, the fixed enzyme 
is sensitive to high temperature. The enzyme activity decreased dramatically when heated at 
42C for 10 minutes. While keep the fixed enzyme at RT for two days does not affect the 
enzyme activity. Overall, the results may indicate that when the temperature is not beyond to 
denature proteins, the axoneme can stabilize the enzyme. 
 
Overall, this paper discussed the possibility of using flagellar axoneme as a biosynthetic 
template. We tested our hypothesis by expressing the constructs of pBS-FAP20-ER, Bla and 
pKF-RSP3-ER, Bla to rescue the mutant strains of im5 and pf14. Our preliminary data showed 
that both target proteins of ER and Bla could express and localize to flagella with enzymatic 
activity. Also, the fixed enzyme is resistant to freeze-thaw treatment, and flagella regeneration 
increases the output of the target protein. Although the target protein incorporation efficiency 
and enzymatic assay method still need to be improved, this research provides a new perspective 
for applying the axoneme as a biosynthetic template. 
Method and materials 
Strains and cultures conditions 
The strains of cc125, im5, pf14, and the rescue strains im5::FAP20-TEV-ERLBD, im5::FAP20-
TEV-Bla, pf14::RSP3-TEV-ERLBD, and pf14::RSP3-TEV-Bla were made in this study. Strains 







medium with agitation or constant aeration in a Conviron environmental chamber at 21C with 
continuous light. 
 
Constructs and antibodies 
All constructs used for rescue experiments are purchased from GeneScript, including pBS-
FAP20-TEV-ERLBD, pBS-FAP20-TEV-Bla, pKF-RSP3-TEV-ERLBD, and pKF-RSP3-
TEV-Bla. 
 
Rescue of im5 and pf14 
The plasmids of pBS-FAP20-TEV-ERLBD and pBS-FAP20-TEV-Bla were used to rescue the 
im5 strain. The plasmids were linearized with Ssp1 enzyme before they are transformed together 
with the paromomycin-resistant pSI103 plasmid for selection. The plasmids of pKF-RSP3-TEV-
ERLBD and pKF-RSP3-TEV-Bla were used to rescue the pf14 strain. Both plasmids were 
linearized with the enzyme SspI. The electroporation technique was applied to transform 
Chlamydomonas cells. Briefly, im5 or pf14 cells were cultured in 100 ml TAP medium to dark 
green, then transferred to 1 L TAP medium with constant aeration. Check the concentration of 
the cells about 20 hours later. When the concentration reaches 106/ml, the cells are ready to be 
transformed. Totally, 108 cells were collected and re-suspended in 1 ml TAP liquid media 
containing 60 mM sorbitol. 300ul cells’ suspension was transferred to a 4 mm electroporation 
cuvette. For the im5 cells, 600ng linearized pBS-FAP20-TEV-ERLBD to pBS-FAP20-TEV-
Bla together with 300 ng PSI103 plasmids were added and mixed evenly. For the pf14 cells, 600 
ng linearized pKF-RSP3-TEV-ERLBD or pKF-RSP3-TEV-Bla plasmids were added cells and 







no need to co-transform with PSI103 plasmids. The mixture of plasmids and cells in the cuvettes 
were chilled on ice for 5 minutes and then electroporated with an ECM630 electroporator (BTX, 
USA) with the setup parameters of capacitance 50 F, resistance 650 , and the voltage 825 V. 
The cells were recovered on the ice for 15 minutes after electroporation and then transferred to 
10 ml TAP medium with 60 mM sorbital and culture 24 hours in a low light environment for 
furthermore recovery. The next day, cells were collected and plated on TAP plates containing 10 
ng/L paromomycin to grow 4-5 days to obtain transformants. 
 
Prescreening rescue colonies by observing cells’ motility and flagellar assembly 
After 4- or 5-days’ culturing, colonies resistant to paromomycin antibiotic should be visible on 
the plate. The next step is to screen the rescue colonies with the expression of the target protein. 
Because of the motility deficiency of im5 and pf14 cells, the most direct way to screening the 
rescued strains is to observe the motility of the cells. In order to do so, all colonies on the TAP 
plate were transferred to 96-well plates with liquid TAP medium. Observe cells’ motility under 
the Olympus inverted microscope CKX53 after 24 hours of culture. In order to further ensure the 
cells’ motility and flagellar assembly, motile cells from the last step were cultured in 3 ml TAP 
medium in a test tube for two days, then record the cell’s motility with an Axioplan phase 
contrast microscope (Carl Zeiss, Oberkochen, Germany) and 4x objective (Olympus, Tokyo, 
Japan). Movies were taken with a phantom High-Speed Mico-eX2 camera and processed using 
the Cine Viewer software (version 2.6, Vision Research Inc, Prince Edward Island (P.E.I), 
Canada). Movies were imported to Image J for analysis. In order to measure the flagellar length, 
cells were fixed with 1% glutaraldehyde. Images were taken on the Axioplan phase contrast 







segmented line selection tool of Image J (Java 1.8.0_172, https://imagej.nih.gov/ij) was used for 
length measurements.  
 
Flagella isolation and stock solutions 
There are two stock solutions need to be prepared ahead, including 25% sucrose in HMDE buffer 
and 10 x HMDEK buffer. The recipes of each solution are listed below. Below the recipe is the 
protocol of flagella isolation. 
25% sucrose in HMDE (Store at 4C) 
10nM HEPES 
5mM MgSO4 
1mM DTT (add 1000x stock solution right before use) 
0.25mM EGTA 
25% sucrose 
10x HMDEK (Store at 4C)  
10nM HEPES 
5mM MgSO4 
1mM DTT (add 1000x stock solution right before use) 
5mM EDTA 
25mM KCl 
1. Make fresh cultures of the cells for flagella isolation on TAP plate. 
2. Inoculate 100 ml TAP media with fresh cultures from plates and let it grow for 2-3 days and 







3. Inoculate to 4 L volume of TAP media with the above culture with bubbling for 3-4 days 
until it turns dark green. 
4. Harvest cells by spinning them down at 2200 rpm for 7 minutes at 18C (Beckman Coulter, 
USA). 
5. Resuspend the cells in 500 ml 10 mM HEPES pH 7.5. 
6. Allow flagella regenerate in HEPES with bubbling for 1 hour in low light conditions. 
7. Check the cells under 100x objective microscope that all cells have flagella. 
8. Spin cells down in 250 ml conical tubes at 2200 rpm for 7 minutes at 18C (Beckman 
Coulter, USA) and resuspend the cells in 100 ml HEPES. 
9. Deflagellate by adding 0.5 M acetic acid to pH 4.5. Quickly check cells under the microscope 
to make sure that deflagellation is complete and then quickly bring the pH to 7.0 by adding 
drops of 0.5 M KOH. 
10. Keep cells on ice immediately after deflagellation and orderly adding the following stock 
solutions to yield the respective final concentration (Table 3-1): 
Table 3-1 Reagents added to the solutions 
Stock solution Final concentration Volume/100ml 
1M MgSO4 (200X) 5mM 0.5ml 
1M DTT (1000) 1mM 0.1ml 
50% sucrose (10X) 5% sucrose 10ml 
0.5M EGTA (2000X) 0.25mM 50l 
100mM PMSF (100) 1mM 1ml 
 







12. Centrifuge at 2200 rpm for 7 minutes at 4C. 
13. Collect the supernatant to 50 ml round-bottom tubes and collect flagella by centrifuge at 
10,000 rpm for 10 min at 4C with a SW 32 Ti motor (Beckman Coulter, USA).  
14. Resuspend the flagella in 1x HMEDK buffer and store the isolated flagella at -20C. 
 
Flagella regeneration 
The protocol of flagella regeneration is modified slightly upon the flagella isolation method. 
Instead of underlay with 25% sucrose immediately after step 10, the flagella and cell bodies were 
separated by centrifuging at 2000 rpm, 5 minutes, 18C. The supernatant is containing the 
flagella and subjected to the 25% sucrose underlay to collect flagella, while the cell bodies were 
resuspended in 500 ml HEPES to culture 1-2 hours in bubbling to regenerate flagella. Repeat this 
repeat if needed to regenerate flagella for more than one time. 
 
ER binding assay 
FAP20-ER and RSP3-ER flagella were subjected to the ER binding assay. Bioluminescence 
estrogen assay was conducted first to build the standard line [264]. 17--estradiol was used as 
the substrate of the estrogen receptor binding chemical. Briefly, different dilutions of 17--
estradiol ranged from 10-9 M to 10-5 M were incubated with BLYES strain and then measure the 
bioluminescence in a Perkin-Elmer Victor. Based on the standard line, 10-7 M of 17--estradiol is 
the half effective concentration. This concentration is used in the following ER binding assay. 
200 l flagella of WT, FAP20-ER and RSP3-ER were incubated with 10-7 M of 17--estradiol 
in a 5ml volume system for overall 48 hours. Each reaction has a duplicate. At the time points of 







estrogen assay. The flagella were removed by centrifuging at 10,000 rpm before the assay. The 
concentration of rest 17--estradiol in the supernatant can be calculated based on the standard 
line.  
 
Beta-lactamase activity assay 
The assay is conducted following the protocol of Beta Lactamase Activity Assay Kit 
(Colorimetric) (ab197008). The principle of the assay is based on the hydrolysis of the substrate 
Nitrocefin, which generates a colored product that can be detected at OD490 nm. The absorbance 
of A490 is directly proportional to the amount of beta-lactamase activity. First, set up a standard 
curve. Prepare a various dilution of hydrolyzed Nitrocefin solutions, 0 nM, 4 nM, 8 nM, 12 nM, 
16 nM, and 20 nM, measure output immediately on a colorimetric microplate reader at OD 490 
nm to obtain the corresponding absorbance. Secondly, prepare flagella samples for enzymatic 
activity assay. FAP20-Bla, RSP3-Bla, WT flagella are subjected to the beta-lactamase activity 
assay. The flagella of WT are used as a negative control. In order to ensure the readings are 
within the standard value range, each of the flagella samples was diluted 10, 20, and 100 times in 
the final volume of 100 l to perform the test. The reaction mix set up is according to the 
protocol. The flagella suspension buffer HMDEK was used as a negative control. Measure 
absorbance on a microplate reader at OD 490 nm in a dynamic mode, every 1-2 minute, for 20 
minutes at RT protected from light. 
 
Flagella recycle done by centrifuging the reactant at 10,000 rpm, 10 minutes, 4C. The 
supernatant was discarded, and the flagella were washed two times with HMEDK buffer to 







l Beta-Lactamase Assay buffer and 5 l HMDEK buffer to keep the same setup with the 
previous reaction and catalyze a new reaction. 
 
Beta-Lactamase Activity were expressed as nmoles/min hydrolyzed Nitrocefin generated per g 
of protein (mU/g). The protein amount of each sample per reaction were calculated as below: 
• Commercial Bla: Recombinant protein equals 0.5 g/l, added 5 l per reaction, total 
protein amount equals 0.5 g/l x 5 l = 2.5 g. 
• WT flagella: 1.6 g/l x 5 l = 8 g. 
• FAP20-Bla flagella: First, ratio of FAP20 and -tubulin numbers were calculated in the 
96 nm repetitive axoneme structure. FAP20 repeat every 8 nm and distributed along 9 
doublet microtubules, therefore number of FAP20 equals (96/8) x 9 = 108. The number 
of Bla equals FAP20, which is 108. , -tubulin dimers are 8 nm long and compose 9 
doublet microtubules and a center pair of singlet microtubules. The number of , -
tubulin dimer equals (96/8) x [(13+9) x 9 + 13x2] = 2688. Second, because the molecular 
weight of FAP20-Bla is 40 kd and molecular weight of dimer is 100 kd, the mass ratio of 
Bla and , -tubulin dimer equals (2688/108) x (100/40) = 62. Finally, the mass of Bla in 
the FAP20-Bla flagella sample equals (1.6 g/l x 5 l)/62 = 0.13 g. 
• RSP3-Bla flagella: First, ratio of RSP3 and -tubulin numbers were calculated in the 96 
nm repetitive axoneme structure. Radial spoke has an average number of 2.5 every 96 nm 
and forms a dimer, therefore number of RSP3 equals 2.5 x 2 x 9 = 45. The number of Bla 
equals RSP3, which is 45. The number of , -tubulin dimer equals 2688. Second, 







tubulin dimer is 100 kd, the mass ratio of Bla and -tubulin equals (2688/45) x (100/100) 
= 60. Finally, the mass of Bla in the RSP3-Bla flagella sample equals (1.6 g/l x 5 
l)/60 = 0.13 g. 
Once the commercial Bla enzyme or flagella samples mixed with nitrocefin to start the reaction, 
the absorbance of 490 nm was measured every minute until the absorbance reach plateau. The 
concentration of the products can be calculate based on the standard line y = 0.0185x + 0.0318. 
The enzymatic activity is calculated at 1 min, 2 min, and 3 min, then the final enzymatic activity 









SUMMARY AND FUTURE DIRECTION 
Part I 
The interplay between O-GlcNAc and primary cilia in regulating energy homeostasis 
In this study, we identified that O-GlcNAc is a negative regulator of primary ciliary length. The 
higher of O-GlcNAcylation levels, the shorter the primary ciliary length. The lower the O-
GlcNAcylation levels, the longer the primary ciliary length. Also, the O-GlcNAc modification of 
-tubulin and HDAC6 promotes the ciliary disassembly. 
 
O-GlcNAc as a PTM generally happens on Ser/Thr of the target proteins and participates in 
almost all of the cellular processes. Here, we showed that O-GlcNAc in involved in ciliary length 
regulation. The O-GlcNAc modification happens on both axoneme protein -tubulin and key 
ciliary length regulators, such as HDAC6, and positively regulates ciliary disassembly. Because 
the previous studies showed that PTMs is one of the major factors involves in ciliary assembly 
and disassembly through acting on the axoneme proteins and critical regulators, our finding adds 
a new modification of O-GlcNAc in regulating ciliary length. 
 
Besides O-GlcNAc as a PTM, O-GlcNAc is more function as a nutrient sensor. The cellular O-
GlcNAcylation levels highly depend on the metabolite state of the cell [129], which is also a key 
regulator of ciliary length. Several investigations showed that primary ciliary length regulation is 
affected by nutrient status and cellular metabolic levels [265]. First, the glucose deprivation, 
decreased ciliary length but promoted primary cilium formation in cultured cells [131]. 







diabetic mouse eyes, trachea, and skin cells compared to wild type, and increased the levels of 
O-GlcNAcylation of RPE1 cells in culture medium impaired ciliogenesis [130]. In addition, 
human obese individuals also have shortened and compromised functional primary cilia of 
adipose-derived mesenchymal stem cells (ASCs). Elevated activity of Aurora A and HDAC6 is 
contributed to the shortening of the ciliary length [132]. More importantly, in chow-diet-fed lean 
mice, the primary ciliary length on the hypothalamic arcuate (ARC) neurons is longer by about 
5.5  0.44 m on average. However, average ciliary length reduced by 40%-60% in the 
hypothalamus of diet-induced obese (DIO) mice that are fed with a high-fat, high-sucrose diet 
[125]. These results strongly indicate that energy homeostasis is vital for maintaining primary 
ciliary length. Meanwhile, an intriguing question is arising: whether O-GlcNAc is the factor that 
contributes to the primary ciliary length regulation in response to nutrient status change? 
 
The importance of hypothalamic neurons in regulating energy homeostasis 
In order to answer the question above, it is essential to understand the energy homeostasis 
regulation first. Recent molecular studies reveal that the hypothalamus of the central nervous 
system (CNS) is the central hub that balances feeding and energy expenditure and regulates the 
energy homeostasis in mammals [266, 267]. The hypothalamus is composed of distinct types of 
nuclei that respond to neuronal hormones in the bloodstream and receive peripheral hormones 
without blood-brain barrier leaking. The peripheral hormones may include growth hormone, 
prolactin, insulin, insulin-like growth factor- I and II, and leptin. The ARC in the hypothalamus 
is critical for sensing and responding to the peripheral circulating metabolic hormones and 
nutrients signals. The location of ARC is adjacent to the median eminence (ME) and third 







neurons in the ARC that respond to orexigenic (which stimulate appetite) and anorexigenic 
(which inhibit appetite), respectively. One group is the neurons producing neuropeptide Y (NPY) 
and agouti-related peptide (AgRP), and the other group is the neurons producing pro-
opiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART). These 
two groups of neurons interact with each other through hormone receptors-mediated signaling 
transduction to control food intake and energy homeostasis in the hypothalamus [271-274]. 
 
Interestingly, all four types of ARC neurons are ciliated and distributed with various receptors to 
bind and respond to hormones, such as the adipocyte hormone leptin and the pancreatic hormone 
insulin [275-277]. The leptin receptors (LepR) and insulin receptors (IR) are trafficking to the 
NpY and the POMC neurons, and are responsive to leptin and insulin to regulate energy 
metabolic pathways. The binding of leptin to LepR mainly actives the signaling pathways of 
JAK2-STAT3 and PI3K-PKD1-AKT pathways as well as the downstream effectors FoxO1, 
AMPK, and mTOR [278-281]. The activation of STAT3 promotes the expression of the POMC, 
which is a precursor peptide of anorexigenic -melanocyte-stimulating hormone (-MSH) while 
inhibiting the expression of AgRP and NPY to decrease feeding [125, 282-284]. AgRP and -
MSH are ligands acting antagonistically on the same melanocortin 3 and 4 receptors (MC3/4R) 
on the lateral neurons. The -MSH activates MC4R to reduce food intake while AgRP inhibiting 
MC4R to increase feeding [285-287]. Meanwhile, leptin directly increases PI3K activity in 
POMC neurons but inhibits PI3K activity indirectly in AgRP neurons. FoxO1 is a well-known 
target of PI3K-PDK1-Akt kinase cascades. FoxO1 acts as an inhibitor of POMC and an activator 
of AgRP expression in the nucleus. Phosphorylation of FoxO1 by Akt inhibits its translocation 







of POMC to decrease food intake [288-290]. The other cellular fuel sensors mTOR and AMPK 
are also the targets of Akt. The mTOR is activated by leptin mediated PI3K-Akt signaling then 
phosphorylates to inactivate downstream AMPK, and it thereby regulates energy homeostasis. 
Insulin signaling in the POMC and AgRP neurons is important for glucose metabolism [291]. 
Once insulin binds to the IR, IRS will be activated and converge with the leptin pathway at the 
point of PI3K activation [292]. Leptin and insulin interplay through the primary cilia mediated 
signaling pathway of PI3K-PKD1-Akt-FoxO1 to active or inhibited POMC and AgRP neurons 
[291, 293-295]. Therefore, hypothalamic primary cilia are crucial in maintaining energy 
homeostasis through cooperating leptin and insulin signaling pathways. In order to know 
whether O-GlcNAc involved in ciliary length regulation, we need to know the factors 
participating in the ciliary length regulation. 
 
The regulation of ciliary length in hypothalamic neurons 
Investigations recently showed the primary ciliary length of hypothalamic neurons shorten in 
either genetic or diet-induced obesity mouse, which further indicates primary ciliary length is 
tightly correlated with signaling transduction and energy status in the body [210]. For example, 
diet-induced obese (DIO) mice, leptin-deficient (LEPR-deficient) ob/ob mice, and leptin 
receptor-deficient db/db mice all exhibit shorter hypothalamic neuron cilia [125]. Shortening of 
ciliary length in ob/ob mice can be rescued by leptin administrations, which indicate that 
hypothalamic ciliary length can be regulated dynamically by metabolic conditions in adult mice 
[125, 210]. Also, in vitro experiment showed that leptin treatment of primary hypothalamic 
neurons cells elongated ciliary lengths [125, 296]. These data suggested that there is an interplay 







showed leptin mediated signaling molecules, such as JAK2 and PI3K, are also involved in ciliary 
length regulation. Pharmacological inhibits JAK2 and PI3K or genetically knockdown the 
expression of PI3K blocks leptin-induced primary cilia elongation [296]. Moreover, targets of 
PI3K downstream signaling such as PTEN, AKT, and GSK3 are also involved in ciliary length 
regulation. Knockdown of Pten and Gsk3b increases ciliary length, while overexpression Pten 
and Gsk3b decreases the ciliary length and blocks the effects of leptin treatment on hypothalamic 
neuron cilia [125]. Further work showed that leptin treatment elongates ciliary length by 
inhibiting PTEN and GSK3 signaling and increasing the expression of IFT proteins [296]. 
These results strongly suggest that primary ciliary length is critical for stimulating LepR-
mediated leptin signaling pathways in hypothalamic neurons. Investigations also showed that 
insulin might promote ciliary growth in parallel with leptin. Insulin signaling is integrated with 
the PI3K signaling pathway, and insulin treatment increases ciliary length up to 25% in 
hypothalamic neurons [125]. It is worth investigating whether O-GlcNAc level is higher in the 
hypothalamic neurons of obese mice. If it is so, it will build a connection that O-GlcNAc 
mediates the energy metabolic dysregulation induced ciliary length abnormally. It can be tested 
by formulating the hypothesis that O-GlcNAc levels regulate the hypothalamic ciliary length 
mediated by leptin and insulin signaling pathway. 
 
The potential to involve O-GlcNAc in ciliary length regulation in hypothalamic neurons 
Even though there is no direct evidence showing the linkage between O-GlcNAc and primary 
ciliary length in the hypothalamic neurons, current findings showed some hints O-GlcNAc is 
involved in the regulation of leptin and insulin signaling pathways; hence, it may affect ciliary 







regulated. For example, STAT3, PI3K, PKD1, Akt, FoxO1, AMPK, IR, and IRS are all O-
GlcNAcylated and respond to leptin and insulin. For other components, even though they are not 
O-GlcNAcylated directly, their activity is highly regulated by cellular O-GlcNAcylation levels, 
such as JAK2 and PI3K/AKT/mTOR axis [137, 141, 297-299]. It is considered that O-
GlcNAcylation acts as a negative regulator of insulin and a positive regulator of leptin signaling 
pathways [131]. Since both primary cilia and O-GlcNAc are intensively involved in leptin and 
insulin signaling, it is worth to investigate the role of O-GlcNAc in response to energy 
metabolism in the hypothalamus.  
 
The importance of O-GlcNAc in regulating homeostasis through the hypothalamus 
The importance of O-GlcNAc in regulating energy homeostasis through hypothalamic neurons 
was reflected in the ablation of OGT in AgRP neurons. Once the AgRP neurons were activated 
by signals such as fasting, browning of the white adipose tissue will be suppressed in order to 
inhibit energy expenditure. However, abolishing OGT in AgRP neurons failed excitation of 
AgRP neurons, therefore promoting the browning of white adipose tissue and protecting the 
mutated mice against diet-induced obesity and insulin resistance. Even though there were a 
higher OGT expression and O-GlcNAcylation levels in the hypothalamic neurons compared to 
the peripheral tissues, elevated O-GlcNAc levels is a signal to active AgRP neurons under 
fasting conditions [300]. However, the other paper reported that Oga+/- mice are increased energy 
expenditure by promoting whited adipose tissue browning [301]. The contradictory phenomenon 
may be because the mutation target regions are different, OGT KO is induced in AgRP neurons 
specifically, while OGA heterozygote mice are generated in the whole body. The results indicate 







hypothalamic neurons. Next, it is important to know whether altering of O-GlcNAc levels in 
response to nutrient status is the reason caused ciliary length changing. 
 
The potential mechanism of O-GlcNAc to regulate hypothalamic ciliary length to maintain 
energy homeostasis 
There are two investigations showing that the potential of O-GlcNAc regulates ciliary length in 
the hypothalamus neurons. First, the work of Dai et al. showed that conditional knockout 
neuronal OGT by crossing CaMKII-Cre(+) and Ogtloxp(+)/loxp(+) mice led more food intake, body 
weight gain, insulin resistance, and elevated serum leptin level, which are prediabetic symptoms. 
The mechanism studies revealed that decreased neuron cells and LepR in the hypothalamic 
contributed to the up-regulated appetite and insulin/leptin resistance [302]. The results indicate 
that the correlation between the diminished neuronal O-GlcNAcylation levels, the attenuated 
leptin and insulin signaling transduction, and the potential dysfunction of primary cilia in neuron 
cells. Another finding revealed that mutation of LepR induced diabetic (DB) mice (Leprdb/Nju) 
showed both ciliary defects and elevated O-GlcNAcylation levels in multiple tissues of mutant 
mice [130]. The following in vitro experiments results showed that increasing O-GlcNAcylation 
levels of RPE1 cells in culture medium impaired ciliogenesis and decreased the ciliary length. It 
is possible that the elevated O-GlcNAcylation level decreased ciliary length in the DB mice. It is 
inevitable to notice that lacking or deficient of LepR is the main reason causing obesity or 
diabetes of the mutant mice in both studies. These observations provide further possibilities that 
O-GlcNAc may regulate ciliary length through integrating with LepR mediated signaling to 








In order to test the hypothesis that O-GlcNAc promotes LepR recruiting to the cilium and actives 
leptin signaling molecules to regulate ciliary length, several experiments can be done. After 
knockdown or pharmacological inhibition of the enzyme OGT/OGA in the primary 
hypothalamic neuron cells, then tests whether the hypothalamic ciliary length changed under 
different cellular O-GlcNAcylation levels. If O-GlcNAc is involved in the ciliary length 
regulation in the hypothalamic neurons, then the recruitment of LepR on the primary cilia and 
leptin signaling activity will be detected. More importantly, the hypothalamic ciliary length 
should be observed in OGT or OGA heterozygote mutant mice. If there is an interplay between 
O-GlcNAc and primary ciliary length, it will build a connection of O-GlcNAc and ciliary length 









Advantages of using flagella axoneme as a biosynthetic template 
This work described using axoneme proteins FAP20 and RSP3 as an adaptor to link a protein of 
interest and incorporate the fusion protein on the axoneme. There are several advantages to do 
so, such as products can be calculated mathematically, isolated simply, regenerated to increase 
the yield, and made more stable during the storage. In the study, we tested the ability of 
Chlamydomonas expressing the fusion proteins FAP20-ER, Bla and RSP3-ER, Bla. Our 
results showed that the fusion proteins successfully expressed and assembled on the axoneme; 
the yield of the target protein ratio in two strains is roughly consistent with the ratio of the 
adaptor protein of FAP20 and RSP3, which indicated the incorporation efficiency of the target 
protein on the axoneme is high; the yield of the target protein can be accumulated by flagella 
regeneration; the target proteins are enzymatically active; the axoneme is recyclable; and the 
stability of the target protein is durable during the storage. These preliminary tests on the 
hypothesis are inspiring. The results indicate the high possibility of applying flagella axoneme as 
a biosynthetic template. However, in order to improve the application, refined conditions are 
needed, specifically, improving the incorporation rate of the target protein on the axoneme, 
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Table A-1. Antibodies used in this study 
Antibody Dilution                 Source 
 WB IF  
O-GlcNAc (RL2)                  1:1000 NA       Santa Cruz sc-59624 
OGT (H-300) 1:1000 NA       Santa Cruz sc-32921 
HDAC6 (D2E5) 1:1000 NA       Cell Signaling 7558S 




      Sigma-Aldrich 017M-4806 
-Tubulin (B-7) 1:100 NA       Santa Cruz sc-5286 
HA (3F10) 1:200 1:100       Sigma-Aldrich 12013819001 
-actin (C4)                           1:10000 NA       Santa Cruz sc-47778 
ER 1:200 NA       CTS 8644S 
Beta-lactamase 1:100 NA       Sc-66062 
FAP20 1:2000 NA       homemade 
RSP1 1:5000 NA       homemade 
IF, immunofluorescence; NA, not application; WB, Western blot. 
 
